JPH045287A - Reagent for determining vitamin ds and production thereof - Google Patents
Reagent for determining vitamin ds and production thereofInfo
- Publication number
- JPH045287A JPH045287A JP2105046A JP10504690A JPH045287A JP H045287 A JPH045287 A JP H045287A JP 2105046 A JP2105046 A JP 2105046A JP 10504690 A JP10504690 A JP 10504690A JP H045287 A JPH045287 A JP H045287A
- Authority
- JP
- Japan
- Prior art keywords
- formula
- tables
- formulas
- chemical formulas
- general formula
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 238000004519 manufacturing process Methods 0.000 title claims description 17
- 239000003153 chemical reaction reagent Substances 0.000 title claims description 15
- 229940088594 vitamin Drugs 0.000 title description 4
- 229930003231 vitamin Natural products 0.000 title description 4
- 235000013343 vitamin Nutrition 0.000 title description 4
- 239000011782 vitamin Substances 0.000 title description 4
- 150000003722 vitamin derivatives Chemical class 0.000 title description 4
- 150000001875 compounds Chemical class 0.000 claims abstract description 41
- 239000000126 substance Substances 0.000 claims abstract description 26
- QYSXJUFSXHHAJI-XFEUOLMDSA-N Vitamin D3 Natural products C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C/C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-XFEUOLMDSA-N 0.000 claims abstract description 9
- 235000019166 vitamin D Nutrition 0.000 claims abstract description 9
- 239000011710 vitamin D Substances 0.000 claims abstract description 9
- 229930003316 Vitamin D Natural products 0.000 claims abstract description 8
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 claims abstract description 8
- 150000003710 vitamin D derivatives Chemical class 0.000 claims abstract description 8
- 229940046008 vitamin d Drugs 0.000 claims abstract description 8
- 125000006850 spacer group Chemical group 0.000 claims abstract description 7
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 claims abstract description 6
- 239000002207 metabolite Substances 0.000 claims abstract description 6
- 235000019155 vitamin A Nutrition 0.000 claims abstract description 6
- 239000011719 vitamin A Substances 0.000 claims abstract description 6
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 claims abstract description 5
- 229940045997 vitamin a Drugs 0.000 claims abstract description 5
- 238000000034 method Methods 0.000 claims description 17
- 239000002253 acid Substances 0.000 claims description 7
- DUIOPKIIICUYRZ-UHFFFAOYSA-N semicarbazide Chemical compound NNC(N)=O DUIOPKIIICUYRZ-UHFFFAOYSA-N 0.000 claims description 7
- 238000001514 detection method Methods 0.000 claims description 6
- 125000000217 alkyl group Chemical group 0.000 claims description 3
- 229910052757 nitrogen Inorganic materials 0.000 claims description 3
- 238000004445 quantitative analysis Methods 0.000 claims description 3
- 230000008878 coupling Effects 0.000 claims description 2
- 238000010168 coupling process Methods 0.000 claims description 2
- 238000005859 coupling reaction Methods 0.000 claims description 2
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims description 2
- 125000004433 nitrogen atom Chemical group N* 0.000 claims 2
- 125000002897 diene group Chemical group 0.000 claims 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims 1
- 238000004040 coloring Methods 0.000 abstract description 2
- 125000004029 hydroxymethyl group Chemical group [H]OC([H])([H])* 0.000 abstract description 2
- 239000000463 material Substances 0.000 abstract description 2
- 238000002360 preparation method Methods 0.000 abstract description 2
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 abstract 1
- 239000013078 crystal Substances 0.000 description 47
- 239000000243 solution Substances 0.000 description 47
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 46
- 238000006243 chemical reaction Methods 0.000 description 40
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 30
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 24
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 22
- 239000002904 solvent Substances 0.000 description 22
- 229910052739 hydrogen Inorganic materials 0.000 description 18
- IAZDPXIOMUYVGZ-WFGJKAKNSA-N Dimethyl sulfoxide Chemical compound [2H]C([2H])([2H])S(=O)C([2H])([2H])[2H] IAZDPXIOMUYVGZ-WFGJKAKNSA-N 0.000 description 15
- 238000005160 1H NMR spectroscopy Methods 0.000 description 13
- 239000000203 mixture Substances 0.000 description 13
- 238000010992 reflux Methods 0.000 description 12
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 11
- 239000010410 layer Substances 0.000 description 11
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 10
- 239000001257 hydrogen Substances 0.000 description 10
- 239000007788 liquid Substances 0.000 description 10
- 239000000047 product Substances 0.000 description 10
- 238000005481 NMR spectroscopy Methods 0.000 description 9
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 9
- 238000010898 silica gel chromatography Methods 0.000 description 9
- 238000003756 stirring Methods 0.000 description 9
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 8
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Chemical compound [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 description 8
- 239000011541 reaction mixture Substances 0.000 description 8
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 6
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 5
- 230000002378 acidificating effect Effects 0.000 description 5
- 238000010531 catalytic reduction reaction Methods 0.000 description 5
- 238000000921 elemental analysis Methods 0.000 description 5
- VLKZOEOYAKHREP-UHFFFAOYSA-N hexane Substances CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 5
- 239000010446 mirabilite Substances 0.000 description 5
- 238000000926 separation method Methods 0.000 description 5
- 239000000725 suspension Substances 0.000 description 5
- NGNBDVOYPDDBFK-UHFFFAOYSA-N 2-[2,4-di(pentan-2-yl)phenoxy]acetyl chloride Chemical compound CCCC(C)C1=CC=C(OCC(Cl)=O)C(C(C)CCC)=C1 NGNBDVOYPDDBFK-UHFFFAOYSA-N 0.000 description 4
- WVDDGKGOMKODPV-UHFFFAOYSA-N Benzyl alcohol Chemical compound OCC1=CC=CC=C1 WVDDGKGOMKODPV-UHFFFAOYSA-N 0.000 description 4
- 238000004458 analytical method Methods 0.000 description 4
- 238000004440 column chromatography Methods 0.000 description 4
- 238000010828 elution Methods 0.000 description 4
- 238000004128 high performance liquid chromatography Methods 0.000 description 4
- 239000012044 organic layer Substances 0.000 description 4
- 229910000027 potassium carbonate Inorganic materials 0.000 description 4
- 150000003839 salts Chemical class 0.000 description 4
- -1 semicarbazide compound Chemical class 0.000 description 4
- 239000000741 silica gel Substances 0.000 description 4
- 229910002027 silica gel Inorganic materials 0.000 description 4
- 101100333190 Saccharomyces cerevisiae (strain ATCC 204508 / S288c) PRT1 gene Proteins 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 3
- 150000001732 carboxylic acid derivatives Chemical class 0.000 description 3
- 239000003054 catalyst Substances 0.000 description 3
- 238000005259 measurement Methods 0.000 description 3
- 239000011259 mixed solution Substances 0.000 description 3
- 230000003647 oxidation Effects 0.000 description 3
- 238000007254 oxidation reaction Methods 0.000 description 3
- 229910052717 sulfur Inorganic materials 0.000 description 3
- AOSZTAHDEDLTLQ-AZKQZHLXSA-N (1S,2S,4R,8S,9S,11S,12R,13S,19S)-6-[(3-chlorophenyl)methyl]-12,19-difluoro-11-hydroxy-8-(2-hydroxyacetyl)-9,13-dimethyl-6-azapentacyclo[10.8.0.02,9.04,8.013,18]icosa-14,17-dien-16-one Chemical compound C([C@@H]1C[C@H]2[C@H]3[C@]([C@]4(C=CC(=O)C=C4[C@@H](F)C3)C)(F)[C@@H](O)C[C@@]2([C@@]1(C1)C(=O)CO)C)N1CC1=CC=CC(Cl)=C1 AOSZTAHDEDLTLQ-AZKQZHLXSA-N 0.000 description 2
- UUZJJNBYJDFQHL-UHFFFAOYSA-N 1,2,3-triazolidine Chemical compound C1CNNN1 UUZJJNBYJDFQHL-UHFFFAOYSA-N 0.000 description 2
- ONBQEOIKXPHGMB-VBSBHUPXSA-N 1-[2-[(2s,3r,4s,5r)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]oxy-4,6-dihydroxyphenyl]-3-(4-hydroxyphenyl)propan-1-one Chemical compound O[C@@H]1[C@H](O)[C@@H](CO)O[C@H]1OC1=CC(O)=CC(O)=C1C(=O)CCC1=CC=C(O)C=C1 ONBQEOIKXPHGMB-VBSBHUPXSA-N 0.000 description 2
- KPGXRSRHYNQIFN-UHFFFAOYSA-N 2-oxoglutaric acid Chemical compound OC(=O)CCC(=O)C(O)=O KPGXRSRHYNQIFN-UHFFFAOYSA-N 0.000 description 2
- HJCUTNIGJHJGCF-UHFFFAOYSA-N 9,10-dihydroacridine Chemical compound C1=CC=C2CC3=CC=CC=C3NC2=C1 HJCUTNIGJHJGCF-UHFFFAOYSA-N 0.000 description 2
- XKRFYHLGVUSROY-UHFFFAOYSA-N Argon Chemical compound [Ar] XKRFYHLGVUSROY-UHFFFAOYSA-N 0.000 description 2
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 2
- 229940126657 Compound 17 Drugs 0.000 description 2
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 2
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 2
- ZBIKORITPGTTGI-UHFFFAOYSA-N [acetyloxy(phenyl)-$l^{3}-iodanyl] acetate Chemical compound CC(=O)OI(OC(C)=O)C1=CC=CC=C1 ZBIKORITPGTTGI-UHFFFAOYSA-N 0.000 description 2
- 239000000853 adhesive Substances 0.000 description 2
- 230000001070 adhesive effect Effects 0.000 description 2
- 150000001413 amino acids Chemical class 0.000 description 2
- 150000001540 azides Chemical class 0.000 description 2
- OWIUPIRUAQMTTK-UHFFFAOYSA-N carbazic acid Chemical compound NNC(O)=O OWIUPIRUAQMTTK-UHFFFAOYSA-N 0.000 description 2
- ULDHMXUKGWMISQ-UHFFFAOYSA-N carvone Chemical compound CC(=C)C1CC=C(C)C(=O)C1 ULDHMXUKGWMISQ-UHFFFAOYSA-N 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- 229940125904 compound 1 Drugs 0.000 description 2
- 229940125773 compound 10 Drugs 0.000 description 2
- 229940126543 compound 14 Drugs 0.000 description 2
- 229940126142 compound 16 Drugs 0.000 description 2
- 239000012043 crude product Substances 0.000 description 2
- 238000000354 decomposition reaction Methods 0.000 description 2
- 150000001993 dienes Chemical class 0.000 description 2
- 238000004821 distillation Methods 0.000 description 2
- 238000001035 drying Methods 0.000 description 2
- 238000000605 extraction Methods 0.000 description 2
- 239000007789 gas Substances 0.000 description 2
- 239000000499 gel Substances 0.000 description 2
- IXCSERBJSXMMFS-UHFFFAOYSA-N hydrogen chloride Substances Cl.Cl IXCSERBJSXMMFS-UHFFFAOYSA-N 0.000 description 2
- 229910000041 hydrogen chloride Inorganic materials 0.000 description 2
- INQOMBQAUSQDDS-UHFFFAOYSA-N iodomethane Chemical compound IC INQOMBQAUSQDDS-UHFFFAOYSA-N 0.000 description 2
- ZLVXBBHTMQJRSX-VMGNSXQWSA-N jdtic Chemical compound C1([C@]2(C)CCN(C[C@@H]2C)C[C@H](C(C)C)NC(=O)[C@@H]2NCC3=CC(O)=CC=C3C2)=CC=CC(O)=C1 ZLVXBBHTMQJRSX-VMGNSXQWSA-N 0.000 description 2
- 238000002844 melting Methods 0.000 description 2
- 230000008018 melting Effects 0.000 description 2
- 229910052760 oxygen Inorganic materials 0.000 description 2
- 239000011591 potassium Substances 0.000 description 2
- 229910052700 potassium Inorganic materials 0.000 description 2
- 238000000746 purification Methods 0.000 description 2
- 238000001953 recrystallisation Methods 0.000 description 2
- 229920006395 saturated elastomer Polymers 0.000 description 2
- 229910052938 sodium sulfate Inorganic materials 0.000 description 2
- RSIJVJUOQBWMIM-UHFFFAOYSA-L sodium sulfate decahydrate Chemical compound O.O.O.O.O.O.O.O.O.O.[Na+].[Na+].[O-]S([O-])(=O)=O RSIJVJUOQBWMIM-UHFFFAOYSA-L 0.000 description 2
- 235000011152 sodium sulphate Nutrition 0.000 description 2
- HPALAKNZSZLMCH-UHFFFAOYSA-M sodium;chloride;hydrate Chemical class O.[Na+].[Cl-] HPALAKNZSZLMCH-UHFFFAOYSA-M 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- 238000001228 spectrum Methods 0.000 description 2
- 238000005406 washing Methods 0.000 description 2
- GLGNXYJARSMNGJ-VKTIVEEGSA-N (1s,2s,3r,4r)-3-[[5-chloro-2-[(1-ethyl-6-methoxy-2-oxo-4,5-dihydro-3h-1-benzazepin-7-yl)amino]pyrimidin-4-yl]amino]bicyclo[2.2.1]hept-5-ene-2-carboxamide Chemical compound CCN1C(=O)CCCC2=C(OC)C(NC=3N=C(C(=CN=3)Cl)N[C@H]3[C@H]([C@@]4([H])C[C@@]3(C=C4)[H])C(N)=O)=CC=C21 GLGNXYJARSMNGJ-VKTIVEEGSA-N 0.000 description 1
- SZUVGFMDDVSKSI-WIFOCOSTSA-N (1s,2s,3s,5r)-1-(carboxymethyl)-3,5-bis[(4-phenoxyphenyl)methyl-propylcarbamoyl]cyclopentane-1,2-dicarboxylic acid Chemical compound O=C([C@@H]1[C@@H]([C@](CC(O)=O)([C@H](C(=O)N(CCC)CC=2C=CC(OC=3C=CC=CC=3)=CC=2)C1)C(O)=O)C(O)=O)N(CCC)CC(C=C1)=CC=C1OC1=CC=CC=C1 SZUVGFMDDVSKSI-WIFOCOSTSA-N 0.000 description 1
- GHYOCDFICYLMRF-UTIIJYGPSA-N (2S,3R)-N-[(2S)-3-(cyclopenten-1-yl)-1-[(2R)-2-methyloxiran-2-yl]-1-oxopropan-2-yl]-3-hydroxy-3-(4-methoxyphenyl)-2-[[(2S)-2-[(2-morpholin-4-ylacetyl)amino]propanoyl]amino]propanamide Chemical compound C1(=CCCC1)C[C@@H](C(=O)[C@@]1(OC1)C)NC([C@H]([C@@H](C1=CC=C(C=C1)OC)O)NC([C@H](C)NC(CN1CCOCC1)=O)=O)=O GHYOCDFICYLMRF-UTIIJYGPSA-N 0.000 description 1
- ITOFPJRDSCGOSA-KZLRUDJFSA-N (2s)-2-[[(4r)-4-[(3r,5r,8r,9s,10s,13r,14s,17r)-3-hydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1h-cyclopenta[a]phenanthren-17-yl]pentanoyl]amino]-3-(1h-indol-3-yl)propanoic acid Chemical compound C([C@H]1CC2)[C@H](O)CC[C@]1(C)[C@@H](CC[C@]13C)[C@@H]2[C@@H]3CC[C@@H]1[C@H](C)CCC(=O)N[C@H](C(O)=O)CC1=CNC2=CC=CC=C12 ITOFPJRDSCGOSA-KZLRUDJFSA-N 0.000 description 1
- JPJGNZQDELRZGE-UHFFFAOYSA-N (phenyl-$l^{2}-phosphanyl)benzene Chemical compound C=1C=CC=CC=1[P]C1=CC=CC=C1 JPJGNZQDELRZGE-UHFFFAOYSA-N 0.000 description 1
- KPZGRMZPZLOPBS-UHFFFAOYSA-N 1,3-dichloro-2,2-bis(chloromethyl)propane Chemical compound ClCC(CCl)(CCl)CCl KPZGRMZPZLOPBS-UHFFFAOYSA-N 0.000 description 1
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 description 1
- KLOFFOUMWOQJNH-UHFFFAOYSA-N 1-(dinitromethoxy)-2-methoxybenzene Chemical compound COC1=CC=CC=C1OC([N+]([O-])=O)[N+]([O-])=O KLOFFOUMWOQJNH-UHFFFAOYSA-N 0.000 description 1
- GXYLXFITCXXCQV-UHFFFAOYSA-N 10-methylacridin-10-ium Chemical compound C1=CC=C2[N+](C)=C(C=CC=C3)C3=CC2=C1 GXYLXFITCXXCQV-UHFFFAOYSA-N 0.000 description 1
- KJDGFQJCHFJTRH-YONAWACDSA-N 16-Ketoestradiol Chemical class OC1=CC=C2[C@H]3CC[C@](C)([C@H](C(=O)C4)O)[C@@H]4[C@@H]3CCC2=C1 KJDGFQJCHFJTRH-YONAWACDSA-N 0.000 description 1
- HFQQYIUTYJVYFZ-UHFFFAOYSA-N 4-methylpentyl 2-cyanoprop-2-enoate Chemical class CC(C)CCCOC(=O)C(=C)C#N HFQQYIUTYJVYFZ-UHFFFAOYSA-N 0.000 description 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 1
- 239000005973 Carvone Substances 0.000 description 1
- 235000006481 Colocasia esculenta Nutrition 0.000 description 1
- 244000205754 Colocasia esculenta Species 0.000 description 1
- 229920000742 Cotton Polymers 0.000 description 1
- YXHKONLOYHBTNS-UHFFFAOYSA-N Diazomethane Chemical compound C=[N+]=[N-] YXHKONLOYHBTNS-UHFFFAOYSA-N 0.000 description 1
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 1
- WSFSSNUMVMOOMR-UHFFFAOYSA-N Formaldehyde Chemical compound O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 description 1
- 241000370541 Idia Species 0.000 description 1
- 229930194542 Keto Natural products 0.000 description 1
- 241000254158 Lampyridae Species 0.000 description 1
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 1
- OPFJDXRVMFKJJO-ZHHKINOHSA-N N-{[3-(2-benzamido-4-methyl-1,3-thiazol-5-yl)-pyrazol-5-yl]carbonyl}-G-dR-G-dD-dD-dD-NH2 Chemical compound S1C(C=2NN=C(C=2)C(=O)NCC(=O)N[C@H](CCCN=C(N)N)C(=O)NCC(=O)N[C@H](CC(O)=O)C(=O)N[C@H](CC(O)=O)C(=O)N[C@H](CC(O)=O)C(N)=O)=C(C)N=C1NC(=O)C1=CC=CC=C1 OPFJDXRVMFKJJO-ZHHKINOHSA-N 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- JCXJVPUVTGWSNB-UHFFFAOYSA-N Nitrogen dioxide Chemical compound O=[N]=O JCXJVPUVTGWSNB-UHFFFAOYSA-N 0.000 description 1
- 240000007594 Oryza sativa Species 0.000 description 1
- 235000007164 Oryza sativa Nutrition 0.000 description 1
- 241000282320 Panthera leo Species 0.000 description 1
- 244000018633 Prunus armeniaca Species 0.000 description 1
- 235000009827 Prunus armeniaca Nutrition 0.000 description 1
- 229920005654 Sephadex Polymers 0.000 description 1
- 239000012507 Sephadex™ Substances 0.000 description 1
- 238000006463 Yamaguchi esterification reaction Methods 0.000 description 1
- LNUFLCYMSVYYNW-ZPJMAFJPSA-N [(2r,3r,4s,5r,6r)-2-[(2r,3r,4s,5r,6r)-6-[(2r,3r,4s,5r,6r)-6-[(2r,3r,4s,5r,6r)-6-[[(3s,5s,8r,9s,10s,13r,14s,17r)-10,13-dimethyl-17-[(2r)-6-methylheptan-2-yl]-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1h-cyclopenta[a]phenanthren-3-yl]oxy]-4,5-disulfo Chemical compound O([C@@H]1[C@@H](COS(O)(=O)=O)O[C@@H]([C@@H]([C@H]1OS(O)(=O)=O)OS(O)(=O)=O)O[C@@H]1[C@@H](COS(O)(=O)=O)O[C@@H]([C@@H]([C@H]1OS(O)(=O)=O)OS(O)(=O)=O)O[C@@H]1[C@@H](COS(O)(=O)=O)O[C@H]([C@@H]([C@H]1OS(O)(=O)=O)OS(O)(=O)=O)O[C@@H]1C[C@@H]2CC[C@H]3[C@@H]4CC[C@@H]([C@]4(CC[C@@H]3[C@@]2(C)CC1)C)[C@H](C)CCCC(C)C)[C@H]1O[C@H](COS(O)(=O)=O)[C@@H](OS(O)(=O)=O)[C@H](OS(O)(=O)=O)[C@H]1OS(O)(=O)=O LNUFLCYMSVYYNW-ZPJMAFJPSA-N 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 1
- 229910052782 aluminium Inorganic materials 0.000 description 1
- 125000003277 amino group Chemical group 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 229910052786 argon Inorganic materials 0.000 description 1
- 125000003118 aryl group Chemical group 0.000 description 1
- 238000003556 assay Methods 0.000 description 1
- 125000004429 atom Chemical group 0.000 description 1
- IVRMZWNICZWHMI-UHFFFAOYSA-N azide group Chemical group [N-]=[N+]=[N-] IVRMZWNICZWHMI-UHFFFAOYSA-N 0.000 description 1
- 238000003287 bathing Methods 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- SLUNEGLMXGHOLY-UHFFFAOYSA-N benzene;hexane Chemical compound CCCCCC.C1=CC=CC=C1 SLUNEGLMXGHOLY-UHFFFAOYSA-N 0.000 description 1
- 235000019445 benzyl alcohol Nutrition 0.000 description 1
- 238000004364 calculation method Methods 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 235000011089 carbon dioxide Nutrition 0.000 description 1
- 239000003245 coal Substances 0.000 description 1
- 238000012875 competitive assay Methods 0.000 description 1
- 229940125797 compound 12 Drugs 0.000 description 1
- 229940125758 compound 15 Drugs 0.000 description 1
- 229940125782 compound 2 Drugs 0.000 description 1
- 229940125810 compound 20 Drugs 0.000 description 1
- 229940126086 compound 21 Drugs 0.000 description 1
- 229940125898 compound 5 Drugs 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 238000002425 crystallisation Methods 0.000 description 1
- 230000008025 crystallization Effects 0.000 description 1
- KPUNOVLMCQQCSK-UHFFFAOYSA-N diazomethane;ethoxyethane Chemical compound C=[N+]=[N-].CCOCC KPUNOVLMCQQCSK-UHFFFAOYSA-N 0.000 description 1
- 230000004069 differentiation Effects 0.000 description 1
- 230000008034 disappearance Effects 0.000 description 1
- 239000006185 dispersion Substances 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 125000004185 ester group Chemical group 0.000 description 1
- VYSYZMNJHYOXGN-UHFFFAOYSA-N ethyl n-aminocarbamate Chemical compound CCOC(=O)NN VYSYZMNJHYOXGN-UHFFFAOYSA-N 0.000 description 1
- 238000001704 evaporation Methods 0.000 description 1
- 235000019256 formaldehyde Nutrition 0.000 description 1
- 238000011065 in-situ storage Methods 0.000 description 1
- 238000002329 infrared spectrum Methods 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 210000003127 knee Anatomy 0.000 description 1
- 238000010667 large scale reaction Methods 0.000 description 1
- JEHCHYAKAXDFKV-UHFFFAOYSA-J lead tetraacetate Chemical compound CC(=O)O[Pb](OC(C)=O)(OC(C)=O)OC(C)=O JEHCHYAKAXDFKV-UHFFFAOYSA-J 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- XELZGAJCZANUQH-UHFFFAOYSA-N methyl 1-acetylthieno[3,2-c]pyrazole-5-carboxylate Chemical compound CC(=O)N1N=CC2=C1C=C(C(=O)OC)S2 XELZGAJCZANUQH-UHFFFAOYSA-N 0.000 description 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 1
- 239000012452 mother liquor Substances 0.000 description 1
- 239000010413 mother solution Substances 0.000 description 1
- 239000007800 oxidant agent Substances 0.000 description 1
- 230000001590 oxidative effect Effects 0.000 description 1
- 238000012856 packing Methods 0.000 description 1
- CPGRMGOILBSUQC-UHFFFAOYSA-N phosphoryl azide Chemical compound [N-]=[N+]=NP(=O)(N=[N+]=[N-])N=[N+]=[N-] CPGRMGOILBSUQC-UHFFFAOYSA-N 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- 238000012746 preparative thin layer chromatography Methods 0.000 description 1
- 230000035755 proliferation Effects 0.000 description 1
- LVTJOONKWUXEFR-FZRMHRINSA-N protoneodioscin Natural products O(C[C@@H](CC[C@]1(O)[C@H](C)[C@@H]2[C@]3(C)[C@H]([C@H]4[C@@H]([C@]5(C)C(=CC4)C[C@@H](O[C@@H]4[C@H](O[C@H]6[C@@H](O)[C@@H](O)[C@@H](O)[C@H](C)O6)[C@@H](O)[C@H](O[C@H]6[C@@H](O)[C@@H](O)[C@@H](O)[C@H](C)O6)[C@H](CO)O4)CC5)CC3)C[C@@H]2O1)C)[C@H]1[C@H](O)[C@H](O)[C@H](O)[C@@H](CO)O1 LVTJOONKWUXEFR-FZRMHRINSA-N 0.000 description 1
- 238000010298 pulverizing process Methods 0.000 description 1
- FFRYUAVNPBUEIC-UHFFFAOYSA-N quinoxalin-2-ol Chemical compound C1=CC=CC2=NC(O)=CN=C21 FFRYUAVNPBUEIC-UHFFFAOYSA-N 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 239000011347 resin Substances 0.000 description 1
- 229920005989 resin Polymers 0.000 description 1
- 229960003471 retinol Drugs 0.000 description 1
- 235000020944 retinol Nutrition 0.000 description 1
- 239000011607 retinol Substances 0.000 description 1
- 235000009566 rice Nutrition 0.000 description 1
- 238000006798 ring closing metathesis reaction Methods 0.000 description 1
- 102220300650 rs181048561 Human genes 0.000 description 1
- 239000000344 soap Substances 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 239000003270 steroid hormone Substances 0.000 description 1
- 238000005092 sublimation method Methods 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- 150000005671 trienes Chemical group 0.000 description 1
- QYSXJUFSXHHAJI-YRZJJWOYSA-N vitamin D3 Chemical compound C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C\C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-YRZJJWOYSA-N 0.000 description 1
- 235000005282 vitamin D3 Nutrition 0.000 description 1
- 239000011647 vitamin D3 Substances 0.000 description 1
- 150000003704 vitamin D3 derivatives Chemical class 0.000 description 1
- 229940021056 vitamin d3 Drugs 0.000 description 1
Landscapes
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Investigating Or Analyzing Non-Biological Materials By The Use Of Chemical Means (AREA)
- Plural Heterocyclic Compounds (AREA)
Abstract
Description
【発明の詳細な説明】
産業上の利用分野
本発明は振光註発色りあるいは化学発光能を有するb能
基な持つ求ジエン試薬とその製法に関する。史にはその
試薬を用いてのcps−ジエンな持つ化合物、特にビタ
ミンD、ビタミンAおよびそれらの代謝物の検出、定置
分析法に関する。
−X
(式中、Xは螢光発色団またはポテンシャル化学発光基
を示し、Yはスペーサーな示す)または−船蔵(a)
x
活性ビタミンD3代謝物の1α、25−ジヒドロキシビ
タミンD、がカルシウム代謝のみならず標的細胞の様々
なものの増殖や分化vhiiする多くの機能な持ったス
テロイドホルモンであることは現在よく知られている。
ビタミンDの生物学的役割を十分理解するために様々な
臨床の場におけるヒト血漿中の主要代謝物の濃度を正確
に知ることは塩蟹なことである。
一般に使用されている競合的結合分析は特異性を欠くの
で、itな代&物は2分析に先立って分けられていなげ
ればならない。また、この分析法は正確さに欠ける。ガ
スクロマトグラフィー−寅蓋分析法は劇1」定の操作が
煩雑であるなどの間組がある。
従ってビタミン9代縮物を分析するための正確で特異的
かつ高感度の方法が必歎とされていた。
各式中、Xは螢″jt、発色団筐たはホテンシャル化学
発光基であり、Yはスペーサーである。
Xの例としては下記式
本発明者らは、ビタミンD、ビタミンAiたはそれらの
代謝物の共役したトリエンの部分と速く特異的かつ定量
的に反応する新規な、に光もしくは化学発光試薬(I)
および(II)を合成した。
本発明の化合物は下記−船蔵(I)および(a)で示さ
れる。
−X
二 二
\ l
+L4 出
二 田
(式中Zは酸の共役塩基を示し;
RおよびR′ は同一でも異なっていてもよ水素原子ま
たはアルキル基を示す)
で示されるものが挙げられる。
Xの好fしい(ハ)としては下記式
である場合が特に好ましい。
一方、Yの例とし℃は下記式
%式%)
(式中、−A−は−0−または−N)I−を示し。
−B−は−NH−−COO−−80□N)i−〔式中Z
は前記と同じ意味2示す〕
で示されるものが挙げられる。式
選ばれた一員を示し、tは1から5までの整数を示し1
mは0から5までの整数を示し、nは0または1のいず
れかを示す〕
で示されるものが挙げられる。但しYのそれぞれの式の
左端は一般蔵il+または(Illの塩の音素原子と。
右端はXと結合する。
Yの好ましい例としては下記式
%式%)
(但しnは前記と同じ意味を示す)で示されるものか卆
けられる。式
A) )リアゾリジンシント/と発色団シントンとの
カップリングによる方法。
である場合か特に好ましい。
本発明の化合物の好ましい例としては。
式
%式%()
セミカルバジド体を最後に閉環する方法。
で表されるものが挙げられる。
本発明σ)−船蔵(I)およびtillで示される化合
物は、以下の徐にして合成される。
(式中。
(V釦
XおよびYは前記と同じ意味な示し。
Qはヒドロキシメチル基またはアミノ基ケ示し。
WはC□−03アルキル基會示す〕
A)法として一般式(V)と(νlI)からDETAILED DESCRIPTION OF THE INVENTION Field of the Invention The present invention relates to a dienephilic reagent having a b-functional group having a vitroscopy coloring or chemiluminescent ability, and a method for producing the same. The present invention relates to the detection of CPS-diene compounds, particularly vitamin D, vitamin A, and their metabolites, using such reagents, and to stationary analysis methods. -X (wherein, It is now well known that steroid hormones have many functions, not only in metabolism but also in the proliferation and differentiation of various target cells. In order to fully understand the biological role of vitamin D, it is essential to accurately know the concentrations of major metabolites in human plasma in various clinical settings. Since the commonly used competitive binding assays lack specificity, the target species must be separated prior to the two assays. Also, this analytical method lacks accuracy. The gas chromatography-tiger lid analysis method has its drawbacks, such as the complicated operation. Therefore, an accurate, specific, and highly sensitive method for analyzing vitamin 9 condensates is required. In each formula, X is a firefly, a chromophore or a chemiluminescent group, and Y is a spacer. Novel photo- or chemiluminescent reagents (I) that react rapidly, specifically and quantitatively with conjugated triene moieties of metabolites.
and (II) were synthesized. The compounds of the present invention are represented by - Shipura (I) and (a) below. Examples include those represented by -X22\l+L4 (in the formula, Z represents a conjugate base of an acid; R and R' may be the same or different and represent a hydrogen atom or an alkyl group). As a preferable f (c) of X, the following formula is particularly preferable. On the other hand, as an example of Y, °C is the following formula % formula %) (In the formula, -A- represents -0- or -N)I-. -B- is -NH--COO--80□N)i- [in the formula Z
has the same meaning as above (2)]. Indicates the selected member of the formula, t indicates an integer from 1 to 5, and 1
m represents an integer from 0 to 5, and n represents either 0 or 1]. However, the left end of each formula of Y is the general stock il+ or (with the phoneme atom of the salt of Ill. The right end is bonded to X. Preferred examples of Y are the following formula % formula %) (However, n has the same meaning as above) (shown) can be opened. Formula A)) Method by coupling of lyazolidine synth/ with chromophore synthon. It is particularly preferable if Preferred examples of the compounds of the present invention include: Formula % Formula % () A method for final ring closure of the semicarbazide compound. The following can be mentioned. The compounds represented by σ)-Funazo (I) and till of the present invention are synthesized in the following steps. (In the formula. (V button X and Y have the same meaning as above. Q represents a hydroxymethyl group or an amino group. W represents a C□-03 alkyl group.) A) As a method, general formula (V) and From (νlI)
【1】を得
る反応または一般式(v1〕とCVD)から(it、l
を傅る反応は。
酸クロリド体Cvu)’r:s水ベンセン等の溶媒に鹸
解し、CV) t cis <Vl) ノ1st水D
M F #Hw加工、 、II流することによって行う
。
B〕法として一般式(vl)から(ll)を侍る反応は
。
無水炭酸カリウム等の共存下(■を無水、エタノール等
の溶媒に懸濁し、1に流することによって行う。
また、V:、薬Il+が不安定な場合、下記反応式のよ
うK11llより用時調製する。
−X
−X
([1)(I)
一般式tillから111を得る反応は、Pb(OAc
)、。
PhI(OAc)2 等の緩和な酸化剤で酸化すること
により行う。
作用
本発明の一般式(I)および(II)で示される化合物
ハ、ビタミンD、ビタミンAおよびそれらの代紺物のc
is−ジエンの部分な特異的に検知する螢光の強い求ジ
エン試薬である。
求ジエングループとして選ばれた4−!l換−1゜2、
4− )リアゾリン−3,5−ジオンは反応性が高く、
緩和な条件下で少量の基質と定置的に反応する。また対
称であるので1穐の幾何異性体しかできないという利点
な持つ。
螢光発色団またはポテンシャル化学発光基として選ばれ
たXで示される基は、高い螢光効率を持っており、また
これらはドリアシリジン環の酸化条件下でも安定である
。
以下に本発明な製造例及び実施例によりて更に詳しく説
明するが2本発明はこれらの製造例及び実施例によって
何ら限定されない。
融点は、微量融点側定器(柳本製作所製)にて測定し、
未補正、IRスペクトルは1日本分光FT/IR−7Q
Q[]型に℃泗」定。MSスペクトルは。
日本電子JMS−D300型にて電子giI撃法(EI
)あるいは1日立M−2000型にてSIMS法にて測
定o’H−NMFIスペクトルは1日本電子GX−27
0型にて御、定し、 tetramethylsll
ane k内す標準として、化学シフトをδ値で示し
た。If+定溶媒は、各化合物ごとに記した。なおり2
0中での測定には、5−(trimethylsily
l ) −propionicacid−d4sodi
um 5alt 9を内部標準に用いた。
NMRの記載は、次σ)略号ニーCッだ。s==sin
glet :d = cloublet ; t =
triplet ; q = quartet ;m
= multiplet ; arom = arom
atic ; br =broad; Big = s
ignal。TLC(薄層りOffトゲラフイー)は、
K18Sell gel GF254(MerCk社製
)を使用。カラムクロマトグラフィーは、特記しない限
り、シリカゲルは、Merck社製Kiesel ge
l 60(35−70mesh) k使用。反応は、ル
ーティンにアルゴン気流下で行なった。
エテル4−インシアナトベンゾエイト(5,05’。
0.026 mot) ノ無水ベンセンl’g(260
suJ中に、室温撹拌下カルバジン酸エテル(3,l’
。
0、033 molを加えた後1反応混合物を2時間加
熱還流した。室温に戻した後、1t′r出結晶を吸引r
取し、粗セミカルバジ)1(7,25)、収率93.9
%)を得た。本島なEtO)iより阿結晶し。
無色鱗片状晶(6,80P)flを得た。
化合物1:
mp 194−195℃
MS m/zN:295(M”、6)、250(7)
、204151゜1676CC=D)
’H−NMR(CDC63+DMSO−d6)δ:1.
28 (3H,t、J=7.3Hz、C:H2CH3
)1.38 (3H,t、J=7.3Hz、CH2C
H3)4.19 (2M 、 Q 、 J=7.3H
z、0H20H3)4.33 (28,q、J=7.
3)1z、CH20H3)7.52及び7.92
(4H、AA’BB’、J:8.6Hz、aromH)
7.70 (IH,br、sig、 NH)7.80
(IH,br、sig、 NH)8.57 (I
H,br、sig、NH)元票分析二計算値
(C;13H17N、0.) : C,52,87;
H,5,sO; N、14.23測定値 : C,
52,71; H,5,72; N、14.14(製造
例2ノ
セミカルバジド1 (I,181P 、 4mmoz)
lItm水EtO)i (5Qa/)に浴解し、粉砕
した無水縦機カリウム(556■、 4mmj)t)を
加えた後1反応液を5時間加熱還流した。減圧下EtO
)iftm去し。
残11EK水冷水を加え、さらに希塩酸ケ用い℃水層1
ki!12註とした。水層は、 ACOEt (3X
60鹸)にて抽出し、 Acogt層は、飽和食頃水に
て洗浄。
無水硫酸マグネシウムにて乾燥し、#媒留去した。
結晶a残ffi(901ag)は、シリカゲルカラムク
ロマトグラフィー(45))にて精製し、10%MeO
H含有Ac0Et #山部よりトライアゾリジン2(8
084’、収率811%〕な結晶状に得。
Ac OEtより鼻結晶し無色針状晶ケ得た。
化合物2
IJ)206〜207℃
MS m/Z(%):249(M”、35)、221
(31)。
2(74(I00)、191(I3)。
IH−NMR(CDC;t、 +DMSO−d、)δ:
1.40 (3H,t、J =7.3Hz、0H20
H,)4.37 (2H,Q、J=7.3)iz、C
H20H3)7.71及び8.10 (4H,AA’
BB’ 。
J =8.9 Hz 、 arom H)10.29
(2M、br、s、2xNH)元素分析:11算値
(C1lH1□N304):C,53,0ろ;H,4,
45;N、16.86測定m :C,53,00
:H,4,51;N、 16.95(製造例3)
く方法1〉
エステA’#2C555m9.145mmot)f)無
水T)IF(8,5j17)溶液なドライアイス及び四
塩化R*浴を用いて一20℃に冷却し、本冷却・撹拌溶
液に水嵩化ジインプデルアルミニウム(642m/ ;
1 mot/l ) kエン溶液)1に一約20分間
にわたって酬加した。反応混合液は、更に一20℃にて
4時間撹拌した後、希塩酸(2su、 19.3mm0
6の塩化水素な含む〕を加えて酸性にした。減圧下塔t
&を留去し得られた残虐な21のシリカケルに吸着し、
シリカゲルカラムクロマトグラフィー(40Sf)に付
しMeした。カラムは、10%MeOH含有cHat3
にて浴出し、臣を含む分画を固陣状(337Iv)に侍
、MeOHK!すMJ&化させ。
純粋なベンジルアルコール体3(240■、収率8’L
4%〕な無色針状晶として得た。
く方法1)−一スケールの大きい反応に適する一エステ
ル陣2(t5761t5.32mmot1用いて、方法
lと一様に反応・後処理な行なった。
塩酸処理後の生成物を水(601117)K懸〜させ。
不溶物な綿栓テ過した。F液は、水にて充填したAmb
erlite XAD −2カラAC700a/)K通
しベンジルアルコール体6な樹脂に吸着させた後。
水(I500a/)tcてカラムな洗浄した。MeOH
を用い℃吸着し℃いる6を溶出すると、固体状物fi(
−117cl)が侮られ1本島′Ik:MeOHzり再
結晶し、ベンジルアルコールに3(794〜、収率60
.6%〕を得た。
化合物6:
mp >aoo℃
MS m/Z(%) :207CM”、 82) 、
178(I DO) 。
148(22)、t32N4)、120(29)、10
7(47)、58(55)。
Br
IRνmaX cs−” : 3344(OH) 、
1682(C=0)’)1−NMFI(DMSO−d、
)δ:4.54 (2H,S、0H2Ph)7.40
(4H,S、aromH)105B <28.S
、2xNH)
元素分析二計算値
(G、H,N、Oj) : C,52,17;H,4,
38;N、 20.28#j定値 : C,51,9
9;H,444;N、20.25インシアンep−二ト
ロアzニル(5,0?。
30.5 mmot ) 、カルバジン飯エテル(3,
91−。
3 Q、 5 mm0t)及び無水ペンゼ:/< 13
0Wit)ノ混合液な15時間、加熱11流した。析出
した淡黄色粗結晶な吸引P取し、べy七ンにてよく洗浄
し。
セミカルバジド4(7,85N、収率97.6%)な得
た。本島y MeOHよりP+結晶し、無色麟片状晶を
得た。
化合物4:
J)216〜217℃ (Li t、 mp21 B−
0〜218.5℃)MS m/Z(%):26B(M
”、0.5)、222(3)。
1553及び1338(NO2)
’H−NMR(DMSO−(I,)δ:t21 (3
H,t、J 〜6.9hz、CH2C;H3)4.08
(2H,Q、J==6.9Hz、CH20H3)7
.73 (2H,br、sig、aromH)8.1
5 (2H,aromH)
8.36.9−02及び948
C!々 IH,br、s、3XN)l)(文献) F、
Arnat、L、Loewe、and A、Tarla
n−AkOn。
Rev、Fac、SCi、Forest Univ、l
5tanbul。
奥、127(I948);
chem、Abstr、、42.8190(I94B)
(製造例5)
粉砕した無水炭酸カリウム(2,5C1,15,2mm
ot )及び無水、EtOH(200at) 9)s〜
g’t 5時間加熱R流した。反応混合液は、黄色から
晰赤色へと変化した。諷圧下EtOHを苗去した敏、残
虐に氷冷水(500d)?r加え、2N HGt vc
−c&註とした。本水層は、Ac0Kt、(3xl 5
0献)にて抽出、芒硝にて乾燥し、 ACOEt Ik
餉去すると。
粗結晶酸生成@(6,7CJ1f)を得、このものゲア
七トンよりP+結晶すると、無色針状晶の5(2,73
t、収率80.7%)が得られた。
化合物5:
mp267−269℃(Lit、mp270.0−27
15℃)セミカルバジド4(4,08?、15.2mm
ot)。
1528及び1348(No□)
’H−NMR(DMSO−d6)δニ
ア、90及び8.34 (4H、AA’ BEy、 J
=9.2H2゜arom H)
10.78 (2H1br、s、2xl)(文献)
G、Zinner and W、Daucker、Ar
ch、Pharm、 。
294.370(I961)
(劣i雪fl16)
化合物6:
mp >soo℃
MS m/Z(%):192(M”、99)、154
(I00)。
NO□ NH2
二トロ15 (787’%’ 、 &54 mmoz
) cbEtDH溶液(60y) i PtO□(80
mg) 存在下、 常圧・富瀉にて水素気流中接触還元
を行なった。水t8開始約40〜50分後1反応容器内
に結晶が析出し始めた。2時間後に理論水素消費量(2
40IE/)Ki!Iしたので反応を終了した。析出結
晶は。
ACOEt及びgtoHを用いて溶解させたfk、セラ
イトな通して吸引濾過した。F液な減圧下溶媒留去する
と粗アミノ体6(720■、収率定量的)な結晶状に得
た。本島は、 EtOH−ACOEt(I: 1; V
/V )にて再結晶すると無色針状晶From the reaction to obtain [1] or general formula (v1] and CVD) (it, l
What is the reaction to that? Acid chloride Cvu)'r:s water Dissolve in a solvent such as benzene, CV) t cis <Vl) 1st water D
MF #Hw processing, , carried out by flowing II. B] The reaction from general formula (vl) to (ll) is as follows. This is done in the presence of anhydrous potassium carbonate, etc. (by suspending ■ in a solvent such as anhydrous or ethanol, and flowing it through 1. In addition, if V:, the drug Il+ is unstable, use K11ll as shown in the reaction formula below. -X -X ([1)(I) The reaction to obtain 111 from the general formula till is Pb(OAc
),. This is done by oxidizing with a mild oxidizing agent such as PhI(OAc)2. Action Compounds represented by the general formulas (I) and (II) of the present invention, vitamin D, vitamin A, and their substitutes.
It is a strongly fluorescent dienephilic reagent that specifically detects the is-diene moiety. 4- selected as the wanted group! l conversion -1゜2,
4-) Riazoline-3,5-dione is highly reactive;
Reacts in situ with small amounts of substrate under mild conditions. Also, because it is symmetrical, it has the advantage that only one geometric isomer can be formed. The groups represented by X selected as fluorescent chromophores or potential chemiluminescent groups have high fluorescent efficiency and are also stable under oxidation conditions of the doriasilidine ring. The present invention will be explained in more detail below with reference to production examples and examples, but the present invention is not limited by these production examples and examples. The melting point was measured using a micro melting point meter (manufactured by Yanagimoto Seisakusho).
Uncorrected, IR spectrum is 1 JASCO FT/IR-7Q
Q [ ] type ℃泗” fixed. MS spectrum. JEOL JMS-D300 model uses electronic giI attack method (EI
) or o'H-NMFI spectrum measured by SIMS method on Hitachi M-2000 model 1 JEOL GX-27
Specified by type 0, tetramethylsll
Chemical shifts are shown as δ values using ane k as a standard. If + constant solvent was written for each compound. Naori 2
For measurements in 0, 5-(trimethylsily
l)-propionicacid-d4sodi
um 5alt 9 was used as an internal standard. The description of NMR is as follows σ) Abbreviation Knee C. s==sin
glet:d=cloublet;t=
triplet; q = quartet; m
= multiplet; arom = arom
atic; br = broad; Big = s
ignal. TLC (Thin Layer Off Togelahui) is
K18Sell gel GF254 (manufactured by MerCk) was used. For column chromatography, unless otherwise specified, silica gel was Kiesel gel manufactured by Merck.
l 60 (35-70mesh) k used. Reactions were routinely performed under argon flow. Ether 4-incyanatobenzoate (5,05'. 0.026 mot) anhydrous benzene l'g (260
In suJ, carbazic acid ether (3,1'
. After adding 0.033 mol, the reaction mixture was heated under reflux for 2 hours. After returning to room temperature, 1t'r of the crystals were sucked out.
Separated, crude semicarbazi) 1(7,25), yield 93.9
%) was obtained. Crystallized from EtO)i on the main island. Colorless scaly crystals (6,80P) fl were obtained. Compound 1: mp 194-195°C MS m/zN: 295 (M”, 6), 250 (7)
, 204151°1676CC=D) 'H-NMR (CDC63+DMSO-d6) δ: 1.
28 (3H, t, J=7.3Hz, C:H2CH3
)1.38 (3H, t, J=7.3Hz, CH2C
H3) 4.19 (2M, Q, J=7.3H
z, 0H20H3) 4.33 (28, q, J=7.
3) 1z, CH20H3) 7.52 and 7.92 (4H, AA'BB', J:8.6Hz, aromH)
7.70 (IH, br, sig, NH) 7.80
(IH, br, sig, NH)8.57 (I
H, br, sig, NH) original ticket analysis two calculated values (C; 13H17N, 0.): C, 52, 87;
H, 5, sO; N, 14.23 Measured value: C,
52,71; H, 5,72; N, 14.14 (Production Example 2 Nosemicarbazide 1 (I, 181P, 4 mmoz)
After bath-dissolving and pulverizing anhydrous vertical mill potassium (556 mm, 4 mmj) t) was added to lItm water EtO)i (5 Qa/), the reaction solution was heated under reflux for 5 hours. EtO under reduced pressure
)iftm left. Add the remaining 11EK water-cooled water, and then add dilute hydrochloric acid to the water layer at 1°C.
ki! 12 annotations. The aqueous layer is ACOEt (3X
60 soap) and the Acogt layer was washed with saturated edible water. It was dried over anhydrous magnesium sulfate, and the solvent was distilled off. Crystal a residue ffi (901ag) was purified by silica gel column chromatography (45)) and purified with 10% MeO
H-containing Ac0Et #Triazolidine 2 (8
084', yield 811%] was obtained in crystalline form. Nasal crystals were obtained from Ac OEt and colorless needle crystals were obtained. Compound 2 IJ) 206-207°C MS m/Z (%): 249 (M”, 35), 221
(31). 2 (74 (I00), 191 (I3). IH-NMR (CDC; t, +DMSO-d,) δ:
1.40 (3H, t, J = 7.3Hz, 0H20
H,)4.37 (2H,Q,J=7.3)iz,C
H20H3) 7.71 and 8.10 (4H, AA'
BB'. J = 8.9 Hz, aroma H) 10.29
(2M, br, s, 2xNH) Elemental analysis: 11 calculation value (C1lH1□N304): C, 53, 0; H, 4,
45; N, 16.86 measurement m: C, 53,00
: H, 4, 51; N, 16.95 (Production Example 3) Method 1> Esthetics A'#2C555m9.145mmot) f) Anhydrous T) IF (8,5j17) solution dry ice and tetrachloride R* bath The cooled and stirred solution was cooled to -20°C using a water volumized diimpdel aluminum (642 m/;
1 mot/l) was added to the solution (1) over a period of about 20 minutes. The reaction mixture was further stirred at -20°C for 4 hours, and then diluted with dilute hydrochloric acid (2su, 19.3mmO
6) was added to make it acidic. Vacuum lower tower t
& is adsorbed to the cruel 21 silica gel obtained by distilling off,
It was subjected to silica gel column chromatography (40Sf) and subjected to Me. The column was cHat3 containing 10% MeOH.
After taking a bath, the samurai, MeOHK! MJ&Made. Pure benzyl alcohol 3 (240 μ, yield 8'L)
4%] as colorless needle crystals. Method 1) - Using one ester group 2 (t5761t5.32mmot1), which is suitable for large-scale reactions, the reaction and post-treatment were carried out in the same manner as in method 1. ~. Passed through a cotton plug to remove insoluble matter. Solution F was Ambly filled with water.
erlite The column was washed with water (I500a/tc). MeOH
When adsorbed at ℃ and eluted 6 at ℃, a solid substance fi(
-117 cl) was despised and recrystallized from MeOHz, and 3 (794 ~, yield 60
.. 6%]. Compound 6: mp > aoo°C MS m/Z (%): 207CM”, 82),
178 (I DO). 148 (22), t32N4), 120 (29), 10
7(47), 58(55). Br IRνmaX cs-”: 3344 (OH),
1682(C=0)')1-NMFI(DMSO-d,
) δ: 4.54 (2H, S, 0H2Ph) 7.40
(4H, S, aromH) 105B <28. S
, 2xNH) Elemental analysis two calculated values (G, H, N, Oj): C, 52, 17; H, 4,
38;N, 20.28#j constant value: C, 51,9
9; H, 444; N, 20.25 incyanep-nitroaznyl (5,0?. 30.5 mmot), carbazine rice ether (3,
91-. 3 Q, 5 mm0t) and anhydrous penze: /< 13
The mixed solution was heated for 15 hours and heated for 11 hours. The precipitated pale yellow crude crystals were collected with suction and thoroughly washed with a bay bottle. Semicarbazide 4 (7.85N, yield 97.6%) was obtained. P+ crystals were obtained from Honjima y MeOH to obtain colorless scale crystals. Compound 4: J) 216-217°C (Lit, mp21 B-
0-218.5°C) MS m/Z (%): 26B (M
”, 0.5), 222(3). 1553 and 1338(NO2)'H-NMR(DMSO-(I,)δ:t21 (3
H, t, J ~6.9hz, CH2C; H3) 4.08
(2H,Q,J==6.9Hz, CH20H3)7
.. 73 (2H, br, sig, aromH)8.1
5 (2H, aromH) 8.36.9-02 and 948 C! IH, br, s, 3XN) l) (literature) F,
Arnat, L., Loewe, and A., Tarla.
n-AkOn. Rev, Fac, SCi, Forest Univ, l
5 tanbul. Back, 127 (I948); chem, Abstr, 42.8190 (I94B)
(Production Example 5) Pulverized anhydrous potassium carbonate (2,5C1,15,2mm
ot) and anhydrous, EtOH (200at) 9)s~
g't Heat R flow for 5 hours. The reaction mixture turned from yellow to bright red. Satoshi, who removed the EtOH under pressure, was cruelly given ice-cold water (500d)? Add r, 2N HGt vc
-c¬e. This aqueous layer is Ac0Kt, (3xl 5
0), dried with Glauber's salt, ACOEt Ik
When you leave it. Crude crystalline acid produced @(6,7CJ1f) was obtained, and when this was P+ crystallized from Geer 7 tons, colorless needle crystals of 5(2,73CJ1f) were obtained.
t, yield 80.7%) was obtained. Compound 5: mp267-269°C (Lit, mp270.0-27
15℃) Semicarbazide 4 (4.08?, 15.2mm
ot). 1528 and 1348 (No□) 'H-NMR (DMSO-d6) δ Near, 90 and 8.34 (4H, AA' BEy, J
=9.2H2゜arom H) 10.78 (2H1br, s, 2xl) (literature)
G., Zinner and W., Daucker, Ar.
ch, Pharm. 294.370 (I961) (low snow fl16) Compound 6: mp > soo℃ MS m/Z (%): 192 (M”, 99), 154
(I00). NO□ NH2 Nitro 15 (787'%', &54 mmoz
) cbEtDH solution (60y) i PtO□ (80y
mg), catalytic reduction was carried out in a hydrogen stream at normal pressure and in a stream of hydrogen. Approximately 40 to 50 minutes after the start of water t8, crystals began to precipitate in the first reaction vessel. After 2 hours, the theoretical hydrogen consumption (2
40IE/) Ki! The reaction was terminated. Precipitated crystals. fk was dissolved using ACOEt and gtoH and suction filtered through Celite. The solvent of liquid F was distilled off under reduced pressure to obtain crude amino compound 6 (720 μm, quantitative yield) in the form of crystals. The main island is EtOH-ACOEt (I: 1; V
/V) to form colorless needle crystals.
【与えた。
’H−NMR(DMSO−d6)+5:5.21 (
2H1br、s、NH2)6.60及び6.97 (
4H1AA’BB’ 。
J =8.6 Hz 、arom H)10.14
(2H,br、s、2xNH)(I!!造例7)
C,tAAN=Q=Q −+01AANH−ン引HNH
■OEt3−クロロプロピルイソサイアネイト(5,C
1゜4’t、smmoz)の無水ベンゼン溶液(I20
a/)にカルバジン酸エチル(5,2SF、5α2 m
moz )な加え、加熱還流1時間行なった。減圧下溶
媒な留去すると粗生成物(9,25? )が結晶状に得
られ1本品なAcOEt−gt、o より再結晶し、
純品のセミカルバジド7C1>59t)’l得た。lh
晶母液(2,24Pl’シリカゲルカラムクロマトグラ
フ4− (Wacogel G−200、I 0Off
) にて!1liL。
2〜5%MeOH含有csctp出部よりさらにZ(5
17av)が得られた。合計収率は、76.0%であっ
た。
化合物7:
mp 107.0−108.5℃
MS m/Z(%り:225(M”+2.0.08)
、223(M”0.2)、178(2)、180(0,
7)。
1721及び1649(C=0)
’H−NMR(CDCl2)δ:
+29 (3H,t、J=6.9Hz、OH,0H3
)2.00 (2H,m、 0H20H20H,)
&39 (2H,m、 −OH,NH−)3.5
9 (2H,t、J=5,8Hz、CtCH2−)4
.21 (2H,q、J==6.9Hz、OH,OH
,)5.68 (IH,m、NH)
6.76及び6.81(各々I H、br、s。
2XN)l)
(I!!造例8)
cz/XAsH−c−NHsHcoogt +セミカ
ルバジド7 (5,256F 、 23.5mmoz)
の無水DMF#液(55Nt)KNaN3(I830P
。
28.2mmoz)k加え、100℃にて6.5時間。
加熱撹拌した。減圧下DMF%:留去し、残渣に水(5
0a/)な加えて、AcOEt(5x70m/)Kて抽
出した。合一したAc0Et #は、水洗、芒硝乾諏し
、L!媒留去すれば、粗アジド陣8(5,131収率9
468%〕が結晶状に得られた。本島なエーテルより貴
結晶し、無色結晶(&6C1)な得た。
化合物8:
J) 81〜82℃
MS m/Z(%):nom−185(2)、141
(3)。
116(2)、104(I00)
2102(N3)
1764及び1671 C0=0)
〆)1−NMR(GDC;t3)δ:
t29 C3H0t、J=7.5Hz、0H20H8
)t80 (2H0m、 0H20H2C)(
2)3.35 (2)1.II+、 −0H
28H−)3.37 (2H,t、J=6.6Hz、
N30H2−)4.21 (2H,q、J=7.3H
z、CH20H3)5.64 (IH,m、NH)
と66及び6.73 (各tr IH,br、s。
2xNH)
(製造例9)
及び無水EtOH(I40d)の懸濁液を加熱還流6時
間行なった。減圧下EtOHな留去し、残渣に水(50
wLl)′Ik加え、2NHC;tにて#酸性とした。
こ0)@陛の水層は、あらかじめ水にて調整しておイタ
Amberlite XAD−22うA(450紅)&
通した。アラムは水(750117)にて水洗した後。
MeOHにて、生成’m11K:樹脂より脱着・溶出さ
せた。
合一したMeOH溶出部*山部留去し、粗結晶生成物を
得、このもの9I′AOOEtより再結晶し、純品の9
(2,58P、収率898%)な、無色−片状品として
得た。
化合物9
m9140〜141℃
MS m/z(%) :noM” 、 141 (20
) 、 129(39) 。
アジド体8(5,6c1.15.6mmot)、粉砕し
た無水炭酸カリウム(2,60? 、 18.7 mm
ot)1667(C=O)
’)(−NMR(DMSO−d6)δ:1.78 (
2H,quirltet、J=6.6Hz。
−CH2Cす20H2−)
3.38 (2H,t、J=6.6Hz)3.43
(2H1t、J=6.6H2)10.06 (2)
1.br、s、2xNH)(製造例10〕
アジドtK9 (t7(In 、 9.23mmoz)
vEtOH<191Lt)及ヒH,O(7,5m/)
K溶解し、10%pa−C:(I77ag)存在下常圧
水素接触還元に付した。Ni!下96時間反応を行なっ
た後1反応液は。
セライトを通して触Sな除去した。F液は、m圧下溶液
協去すると結晶性残渣(I,6291が得られ、H,O
−MeOHより再結晶すると遊離アミノ捧1,0(tO
O7F、収率690%〕が無色針状晶として得られた。
化合物10
J)227〜229℃
129(47)、101 (95)、56(94)。
’H−NMR(D20) δ:
2.00 (2H,m、−CH2にH20H2−)3
.03 (2H,t、J=Z4Hz、0H2NH2)
3.60 (2H、t 、 J =6.6H2、−C
H2−N )化合物10の塩#I1.塩
アジド体9 (I40Iv、 0.76 mmot)’
kEtO)i(20m)及び−塩酸(0,4d)に溶解
し、10%pd −C(305i&)存在下、 3.0
h/ on2水素圧にて中圧接触還元な行なった。冨
温にて4時間後。
反応な終了し、上記と同様に処理すると、10のHCl
塩が結晶状に得られ、 MeOH−Et20 ! r)
再結晶し、純品の1[IHCA塩 (93,Omg)、
収率63.0%〕が無色針状晶として得られた。
MS m/z<9!o):158(M”、100)、1
41(50)。
ジニトロベラトロール11 (2,28F 、 10m
mot)vm温下EtOH(,100a/)に溶解させ
た。−2Pω2(0,23))存在下、室温、常圧水素
気流中接触還元を行なった。撹拌2365時間後、水素
の消費が児全に停止(理論水素消費量1.3t)したの
で反応を終了した。還元生成物は1丁はやく音素気流下
、セライトな通し触媒を除き、F液は、ジエテルケトマ
ロネー) (I741,1()mmot)をあらかじめ
入れておいた反応容器内へ直接導入した。反応混合溶液
は、直ちに加熱還流1時間行なった後、室温にて一晩放
置した。析出した結晶を吸引E取し。
粗結晶生成物12(2,11?、収率75.8%)を得
。
EtOH−OH20t2より再結晶を行ない、黄緑色針
状晶(I98P)を得た。一方、結晶F液(0,80t
〕は、シリカゲルカラムクロマトグラフィー(4Fl)
にて精製し、1%MeOH含有CHC63溶出部より、
さらに12(0,33))を得、合計収率は、840%
であった。
化合物12
mp250−251℃(Lit、255℃)MS m
/Z(%):278℃M 、100)、233(7)
。
’H−NMR(CDO13+CD30D)δ:1.48
(3H,t、J=ZO)12.C1H2C)i3)
3.99及び4.06 (each5H,s、2xO
CH3)4.56 (2H,q、J=ZOHz、CH
2CH3)6.94及び138 (各々 IH,s、a
romH)(文献) z、5uaesinsky a
nd A、Valenta。
Co11ection Czechoslov、Che
m、Commun、。
36.2527(I971)
(製造例12)
NaH(0,26) 、1197mm0t)な無水DM
F(5sl)に懸濁し1本冷却(0℃)、撹拌懸濁液に
、12(2,035’、7.31 mmot)の無水D
MF (60at)溶液を約20分間かけて泗加した。
水素ガスの発生が終わり、溶液の色が黄色から黄褐色に
変化したのを確m&(約20−30分)、ヨウ化メチル
(0,68id、1αq7mmot)を約5分間かけて
滴加した。反応混合溶液は、更に水冷下15時間撹拌後
、氷冷水(I50ILl)中に注ぎ、C;HGt3iX
15QMl)にて抽出した。
GHGt、抽出層は、飽和食塩に℃洗浄、芒硝乾燥。
溶媒留去して、黄色残ac2.74t)k得た。不生成
物は、シリカゲルカラムクロマトグラフィー(I30)
)により*aし、 GHGt3: Benzene(I
:1;v/v)溶出部より、0−メチル体14(0,1
0?、収率4.7%]を淡黄色結晶として。
またcacz3 溶出部からN−メチル体1ノ(I,7
2F。
収率80.4%)な黄色結晶として得た。N−メチル体
1〜6は、EtOH−Et、Oより再結晶し、黄色針状
晶を得、1ノは、 gt、o−n−Hexane J
:り再結晶し、淡黄色針状晶な得た。
化合物16
m9166〜167℃
MS m/Z(%):292(M 、100)、27
8(I1)。
277(I2)、247(I6)、220(45) 、
205(6) 、192(22) 。
’f(−NMR(CDC63)δ:
t44 (3H,t、J=7.0Hz、0H2(J、
)3.73 (3H,s、N−0H3)3.94及び
4.C5(each 3B、 6゜2xoca、)
4.51 (2H,Q、J=7.0Hz、OH,0H
3)6.71及びz56 (each IH,s、a
rom)i)化合物14
mp123〜125℃
MS m/Z(%I):292(M”、100)、2
47(I6)。
220(45)、205(I8)、190’H−NMR
(C;DGt、)−二
t46 (3H,t、J=8.QHz、0H20H,
)4.00 、4.06及び4.16 (each
5H。
S、3xOOH,)
4.52 (2H,q、J=8.0)1z、0H20
H8)7.10及び7.41 (6aChIH,S、
&rOmH)元素分析:計算値
測定WL:
液(51〕を加え、冨温下10分間撹拌した。反応液は
INHCzを用いて弱fIR注とした後、 cHat。
Kて、水層の11元が消失するまで繰り返し抽出した。
合一したCHC/、層は、水洗、芒硝乾V&後、溶媒を
留去し、黄色粗結晶カルボンal15(Q、31゜収率
90.7%l得た。本品は、CHCL3より再結晶な行
ない、黄色針状晶′に得た。
化合物15
mp241−243℃(Lit、m9222℃)MS
m/Z(%):264(M”−27)−220(I00
)−(文献) T、Iwata、 M、Yamagu
chi、 S、Hara。
M、Nakamura、and Y、0hkura。
J、Ghromatogr、、362.209(I98
6)(製造N14)
υ や
N−メチル体13 (D、48t 、 t63mmo4
) ノ1.4−ジオキサン(5m)溶液11CI N
NaOH水溶pルボン酸15 (470m9.178m
moz )及び5OCz、(I0m )の混合溶液な1
時間加熱還流した。減圧下、過剰の5OCz2%:@i
去し、得られた赤褐色結晶會無水ベンゼンーn−ヘキサ
ンより再結晶し、*赤色針状晶の酸クロリド16(43
5Iv。
収率86.6%〕を得た。
化合物16
mp 272−275℃(分解) [Lit、mp26
1℃〕MS m/Z(%り:284(M”+2.21)
、282(M”、62)。
(文献) T、Iwata、 M、Yamaguch
i、S、Hara andM、Nakamura、J、
Ghrormtogr、 、、 362 。
(実施例1〕
酸クロリド16C113jlS’、 0.4mm0L)
fk無水ベンセン(8WLt)に溶解し1本攪拌還
流溶液に、ベンジルアルコール陣3(I24〜、 0.
6 m mot)の無水DMF’(Q、511+17)
溶液な一気に加え、15時間還Rを継続した。6の添加
と同時に黄色沈殿物が生成し始めた。反応液tO℃に冷
却し、析出結晶を吸引枦取し、ベンゼンにて洗浄した。
黄色粗結晶(I84〜)は、クロロホルムにて膨潤シた
セファデックスLH−20カラムクロマトグラフィー<
200d)にてwi製し、5%MeOH含有CHCt3
溶出部より[13[10311g、収率56.8%]を
得た。本品は、 MeOH−CHC;t3 より再結
晶し、黄色結晶な得た。
化合物iIA
mp 279〜280℃(分解〕
MS(+SIMS)m/z:454(M”+1)’H−
NMR(CDC63+DMSO−d、)J:′5.75
(6H,s、N−1c)I3)3.92及び4.0
5(各々3H、s 、 2xOCH,)5.43 (
2H,s、OH2ph)691及びZ36 (各41
H、s 、 arom H)7.54及び7.58
(4H,AAJ3B’ 。
J=8.6Hz、aromH。
10.56 (2H,br、s、 2XNH)元素
分析:計′lI1.値
(C2□H1gN50.)OH30H:C,54,43
; f−i、4.78 ;N、 14.45測定値
: C,54,42;H,4,35;N、14.8
3(実施例2)
液%:案温に戻してから、析出している結晶な吸引P取
すると、jk色粗結晶生成物[IB(I1,3智、収率
55.1%〕が得られた。本島は、極めてJk11i!
註のため、以下の反応には、精製することなく使用する
。
化合物11B
’H−NMFI (DMSO−d6)−二3.78
(3H,s、N−OH,)6.89及び4.03
(各々3H、s 、 2xOcH3)Zlo及びZ47
(各々I H、S 、MOm H)7.45及ヒフ、
85 (4H、AA’ BB’ 。
J=9.0f(z、 arom H)
10.42 (2H,8,2XNH)(製造例15〕
酸クロリド16(20jllf、 Q、07mmoz)
ノ無水ベンセン(2,5id)還流溶液に、 6 (
91111F 、 0.047mmot)ノ無水DMF
(0,1d)溶液な一気に加え1反応混合液は、1時間
、加熱1lijiした。反応ジニトロベラトロール11
(0,91? 、 4 mmot)をEtOH(80
d)に#解し、Pto□(89#)存在下室温にて常圧
水素気流中接触還元を行なった。水素の消費(理論消費
154017)が完全に停止するまで約17時間反応を
継続した。生じた淡黄緑色浴液は、窯素気流中セライト
を通し触媒を除去し、tF液は、2−ケトグルタル酸(
0,58y、4mmoz)な含む反応容器中に@級集め
、直ちに加熱還施した。15時間後1反応?:P、了し
。
反応液な冷却すると、橙黄色結晶が析出して来た。
析出結晶を吸引戸数し、キノキサリノン捧17(0,8
0)、収率71.9%〕を得、 EtO)lより弗結晶
し黄色針状晶(0,62)1−得た。
化合物17
mp250〜252゜
M3 m/z(%り : 278 (M” 、36)
、260 (I00) 。
232(88ン、217(32)、189’H−NMR
<CDC;t3) a :2.80 (2H,t、J
=7.5Hz、−0H2Co−)3、ts (2H,t
、J=7.sHz、’cH−)3.92及び3.93(
各々3H、s 、 2xOCH3)6.78及び118
(各々1H,S、2LrOmH)11.92 (I
H,br、sig、−C;0OH)18 El二G0
0CH8
20h=cooH
く方法I〉
氷冷LりNaH(I76W、 7.3mmoz)o>
無水DMF(3a()懸濁液に、撹拌上化合物17(6
06智、 2.2 mm06) f)無水DMF(20
m)溶液な約20分間かけテM71[IL、 !FLK
0.514関o″CKて撹拌taけた。次に反応容1i
FKヨウ化メチル(455pi 、 7.3mmot)
k約10分間かけて滴加し、全反応液は、引き続き0
℃にて15時間撹拌し、氷冷水(50m)中に注いだ。
混合浴液は。
CHCt3C5x50ml)にて抽出し、有機層は、飽
和食塩水にて洗浄、芒硝乾燥、溶媒留去すると。
粗生成物(570my)が得られた。本成構体は。
シリカゲルカラムクロマトグラフィー(Wacogel
G−200,24))にて精製り、 n−Hexane
:Ac0Et (4: 1−2 : 1 ; v/v
) ty>溶出HよりN−メチル体18(492mg
、収率73o8%)を得MeOH−cHct3 より再
結晶し、淡黄色針状晶を得た。0−メチル体19は、極
微量得られたにすぎなかった(方法I参照)。
一方、 CHO6,抽出後の水層は、Q、5NHC6に
て酸性とした後、5%MeOH含有GHC13にて再抽
出し、有機層は、飽和食塩水にて洗浄、芒硝乾燥、溶媒
留去するとカルボン酸20(86■。
13.5%)が結晶状に得られた。本島fMeOH−c
Hct3 より再結晶すると黄色針状晶が得られた。
く方法l〉
カルボン[17(t00? 、 3.60 mmoz)
%:OH,OL、−MeOH(I: 1 : V/V
、 100WLt)K&濁し、室温撹拌下ジアゾメタ
ンのエーテル浴液V原料の17が消失するまで酬加した
。過剰のジアゾメタンは、急累気流にて留去した後、減
圧下#媒1kftjI去すると、結晶跣残麿(i、14
N)が得られた。本生成物は、シリカゲルカラムクロマ
トグラフ4−(Wacogel C;−2[]0 、5
Qf)Kて軸製し、n−Hexane: Ac0J?:
t(6: 1 ; V/V)溶出部よりO−メチル体1
9 C48011jf、収率43.6%)及びn−f
(exane:Ac0ji:t (I: 1 ;v/v
)溶出部よりN−メチル体18 (5281Iy。
収率48.0%)なそれぞれ得た。0−メチル体19は
、NaOH−CHOP3 !り再結晶し、無色プリズム
晶を得た。
化合物18
mp174−175℃
MS m/z(%):306 CM”、100)、2
74(I5)。
258(I4) 、247(88) 、231(24)
、203(20)
Br
IRymaX5++−1:1740及び1651 (C
=0)’)i−NMR(CDCj3)δ:
2−86 (2)1.t−J=ZIH2−CHzGO
)3.25 (28,t、J=ZIHz、 )−a)C
2−〕6.69及び3.70 (各々3H,S、N−
CH3゜C100CH3)
6.96及び4.01 (各々3H,s、2xOCH
3)6.68及び125 (各々IH,s、aromH
)化合Th19
mp 137〜169℃
MS m/z(%):306 (M”、51)、27
5(I0)。
化合物20
ml)239〜241℃
MS l/Z(%):292 (M” 、533.2
74(99) 。
246(I00)、231(53)、203(41)、
175(27)
Br
IRymaXa*−” :1764及び1628(0=
0)’)1−NMR(DMSO−d6)δ:2.70
(2H,t、J=6.9Hz、0H2CO)&00
(2H,t、J=49Hz、0H2082Go)6−
65 (3H−s −N −G Hs )五84及び
5.94 (各々6H、s、 2xOCH,)6.9
8及び122 (各々IH,SlrOmH)’)l −
NMR(C;DC,C3)δ:2.89 (2H,m
)
3.24 C2H,m)
3.71 (3H0,s、C00CR,)4.00及
び402及び4.07 (各々3H。
、s、5xOC;H,)
7.17及び7.27 (eachll(、s、aro
mH)18 2O
N−メチル体18 (tl 513.75 mmoj
) tl、 4−シ:ir*ty (I8su )及び
I N NaOH7jC溶液(IDia/)K溶解し、
N温下10分間撹拌反応させた。反応混合液は、希塩t
It酸註酸性た後。
10%MeOH含有cHct、にて水層の蓋元か消失す
るまで抽出を−り返した。合一した有機層は。
飽和食塩水にて洗浄、芒硝乾燥、#媒留去し、粗結晶カ
ルボン酸20(I,OFl、収率95.9%〕を得た。
本島は、MeOH−Of(Cz3より再結晶し。
純品20 (852〜〕得、このものは、先に侍てい
る化合!1120 と一致した。
(製造例18)
カルボン酸20 (500Iv、 171 mmot)
t’無水DMF(I2jl/)K溶解し1本撹拌溶液に
トリエチルアミン(0,36wr! 、 2.57 m
moz ) 、 シフ エニにリン酸アジド(0,55
ml 、 2.57 mmol)を顯次滴加した。反応
1時間後にジフェニルリンe17) )” (0,54
mmot) k追加し、史[15時間呈室温撹拌な行な
い、#!黄黄緑色液液傅た。減圧下達やかに浴謀餉去し
、残渣を高真空上乾燥した。乾燥生成物に無水ペンセン
(2011J)’に加え、混合溶液な1時間加熱還流し
た。−度反応液を冨温に戻した後、カルバジン酸エテル
(I78m&。
t711[1m0t)を加えた。反応液は、Mび0.5
時間還IWl、後、史にM湿下0.5時間撹拌し、 #
an−留去した。得られた淡黄色残aC1,976t)
は。
シリカゲルカラムクロマトグラフィー(91:l)にて
精製し、4〜5%M80H含有CHC43溶出郵よりセ
ミカルバジド21 (230m9)”k得た。未分離
分画は、再シリカゲルカラムクロiトゲラフ4−(I5
P)K対し、更に21 (I64mg)を得1合計収
率は58.6%であった。
化合物21
MS m/Z(%):393(M”、5)、347(0
,8)。
ろ30(I)、289(92)、246(47)。
’H−NMR(DMSO−d、)δ:
1.18 (3H,t、J =6.9Hz、0H2C
H3)2.95 (2H,t、J=5.9Hz、CH
20H2NH−)3.52 (2H,m、 CH,
NH)167 (5H,s、N−CH,)
3.89及び3.97 (各々3H,s、2xOCH
3)4.02 (2H,Q、J=6.9Hz、(H2
0H3)6.40 (IH,br、sig、NH)6
.91及びz31 (各々IH,S、lLromH)7
.70 (IH,br、s、NH)8.65 (I
H,br、sig、NH)セミカルバジド21(272
〜、 0.69 mmot) 。
栓枠した無水炭酸カリウム(I91〜、i8mmot)
及びabs EtOH(20ysi )の懸〜敵紮6時
間、加熱還流した。減圧上溶媒留去し、残aK水(60
Mり’に加え、2NHC6Kて酸性とした。水1164
!、 10%MeO)1 *有OHC;t3(3x50
au) Kて抽出し、有機層は、飽和食塩水にて洗浄、
芒硝乾燥、溶媒留去すると、淡黄色結晶(222I4g
)が得られ= MeOf(−CHCL3より爵結晶し、
黄色プリズム晶として、90(I30%’) 9を得た
。結晶母液(70mg)は、シリカゲルカラムクロマト
グラフィー(I(I)にて精製し、5%MeOH含有G
HGt3#a[SC’)更t/Cr1OC64119)
’l得0合計収率は80.8%であった。
化合物−C
ml)250〜255℃
MS Vz(%):547 (M”、5)、289(
2)。
246 (I00) 、231 (35) 、205I
RymaXa*−1:1694及び1640(C=0)
’H−NMR
(DMSO−d6)δ:
3.02 (2)1.t、J=6.9Hz。
3.65 (3H,s、N−0H3)3.80 (
2H,t、J=6.9Hz。
3.84及び3.95 (各々3H,8,2XOCH
3)6.96及びZ26 (各々lH,s、aromH
)9.95 (2H,S、2XNft)る。
(夾施例5)
トリアゾ’) シフ IC(I Q、Qap 、 0.
029mmot)の無水DMF(Im)溶液にPhI(
OAc)、(I12〜、0.035mmot)9を加え
、室温にて1時間撹拌した。減圧下DMFlk貿去する
と赤色固体状残渣か得られた。本島v cH2at2−
benzene zり結晶化すると、極微量であるが
、目的のICの赤色プリズム晶が得られて来た。現在、
大量に純品の10な得るための方法(昇華法等)な検討
中であ財
アミノ捧す(98幅、 0.05 mmot)及び炭鈑
カリウム(I5,2■、 0.11 mmot )の水
溶液(0,25m)に7−クロロ−4−二トロペンゾフ
ラザン(8,34’、α041 mrnol ) ノE
tOH(I−)溶液な約5分間かけて諷加した。生じた
暗紫色溶液は、室温で10分撹拌した後、60−70℃
にて5分間加熱撹拌した。暗紫色反応懸橋液は。
2NHO1Kて酸性にすると暗赤色溶液となった。
減圧下溶媒留去し、得られた残fi(44,5〜)は。
ODSカラムクロマトグラフィー(WaterS社。
分散用ODS充填剤5?)にて&製した。カラムは、2
0%MθOH含有水にて溶出し、トライアゾリジンtl
D C9,5〜、収率70.9%〕を黄赤色粘着性物
質として得た。
化合物[ID
Br
IRνmax cm−” : 1688 (C=0 )
1586及び1301 (NO,)
MS l/Z(%):noM”
’H−NMR(DMSO−d、)a:
t99 (2H,m)
五4−&5 (4H,m)
6.42 (I)1.d、J=9.2Hz、arom
H)851 (IH,d、J=9.2Hz、arom
H)9.42 (If(0m、Nf()
IQ、10 (2H,s、2xNH)(実#ilI例
6)
fiE O
N−メチルアクリジニウム(22〜、0.038m m
ot) 17)無水DMF(0,5mg)il:液に7
t/陣U C7,6Iv、0.048mm06l−加え
、生じた反応懸濁液を外温50−60℃にて6時間加熱
撹拌した。減圧下DMFを留去し、暗黄色残渣(43,
5〜)に塩酸水溶液(0,057mmozの塩化水素に
相当する量)及びMeO)l な加え残&な溶解した
。再び溶媒な留去し、残渣なセファデックスLH−2[
1カラムクロマトグラフイー(551〕にて&灸した。
EtO)1 にてカラムを充填し。
EtOHにて溶出せしめた。溶出容量67〜46dの黄
色分thlt集め化合物rJEc22.4■、収率94
.8%)を得た。
化合物lIE
’H−NMR(DMSO−d6)δ:
167 (2H,m、−HNCH,CH2O)(2−
)2.46 (2H,t、J =7.3Hz、−()
12G−)2.94 (2H0t、J=7.6Hz、
Ph0H2−)3.06 (2H,m −
HNCH2−)5.36 (2H,t、J=6.6f
(z、 −0H2N )4.97 (3H,s、
十N−CH5)746及び7.65 (
4H,AA’ BB’ 。
J:8.6H2,aromH)
7.92 (IHom、 NH)
8.19 (2)1 、 m 、 arom H)
8.57 (2H、m 、 arom H)8.6
2 (2H,d、J=8.6Hz、aromJ8.9
6 (2)1.d、J=9.2Hz、aromH)1
0.10 (2H,br、s、 2XNH)以下に
本発明化合物とビタミンD類との反応例について説明す
る。
(実施例7)
am R1=R2=Rg=H
b= R1=R3=HR2=OH
C=R□:OHR2,F13=f(
d : R、=R2=O)I R3=He = R1
=R3=OHR!=H
く方法1 ) Pb(OAc)4による1邊の酸化、
弓き続りり、A、反応
Vl tamtn D3 22 a (91W
、 0.0 2 4 mm01)L[I A (I
2,9W、 0.028mmot) 、無水DMF(0
,2d)、無水THF(0,3id)及びg4.ACO
H(5μt)の懸濁液を一75℃に冷却し1本撹拌iニ
Pb(OAc)、 (I8,9mg、 0.043 m
mO/−)な加えた。反応懸濁液は、PbC0Ac)4
添加5分後より赤色な帯びて来た。反応液は1時間−7
5℃にて撹拌した後、室温に戻し更に1時間反応な行な
った。反応混合物を氷冷水に注ぎ、cHct3(3X1
5awj)Kて抽出した。cHat3層は、飽和食塩水
にて洗浄、芒硝乾燥、溶媒留去した。得られた黄色粘着
性物質(22,[3W ) ハ、 Preparati
veTLO(Merck社lit 、 5ilica
gel 6OF254゜20 tx (W) X I
Q cm (H) X O,5am (T) X 4枚
、展開溶媒2%MeOH含WC;HC;t3) Kテ精
製シ、主成積体厘a(C6−αH;90■〕 及びその
J!跣体鳳a’ (G、−βH:1.6#)’i’得た
。合計収率は。
555%であった。l a (C6−αH〕は、黄色結
と一−ノ
晶として得られ、MeOH−C;H2O12より杏結晶
し。
黄色針状晶を得た。
化合物−a(G6−αH)
mp 145〜145℃
UVλIJQHnm(log g) : 217 (4
,72) 。
24(Shoulder) 、322(3,80) 。
4ON4.07)。
元素分析二計算値
(048H61N5011−Hρ): C,67,50
:H,7,45: N、8.20゜11J定11
:C,67,08:)1.7.18;N、8.12
゜<方法2> PhI(OAc)2にヨル11A4)
酸化、iJき続くビタミンDとの反応
(Iid ) FItK、 PhI(OAC)、(7,
5av 、 102!1mm0A)t’加え、室温撹拌
下1反応液が十分な赤色な呈するまで約0.5〜1時間
撹拌を継続した。
本赤色溶液ニ、24.25 (OH)、D、22e (
5,Oav。
メーN−)
0.012 mm0L)を加え、溶液の赤色が消失する
まで更Kt5時間撹拌した。減圧上溶媒を留去し。
員纏色粘着註物質(24,1〜)を得、 prepar
ativeTLCCMerck社H5ilica ge
l 60 F2. 。
20cm(W) X 10m(H) X O,5aa*
(T) X 4枚、展8溶媒5%MθOH含@GH2C
L2)に℃精製し、付加体しくc6−αH反βhの混合
物、10.4■。
収率定置的)な非結晶a′R色粘着注物賢として得た。
このようにして得たビタミンD類と本発明試薬との付加
体の異注俸生成比及び収率な第1表に示すつ
ビタミンD3訪導体と本発明臥薬(化合物IA)との付
加物である化合物1c、ld及びIeグ)混合ど\ノ
r−ノ ど−−ノ
液について、 HPLC(高速液体クロマトグラフィー
)による分*V次の条件により行なった。
HPLC分離条件
カラA : Li chrospher 10CIRP
15lel (5,czm)4 aa X 250
m
#*剤: 水:メタノール=27 : 73 (v/v
)流 速: 11/分
検 出二 EX395nm、Em500nm6nP))
/10μtエタノール
結果を第1図に示す。図中、 lc、l(I,letど
N) l\ノ l−一/
は主生成ml Ic’ 、腫d′0膳e′はl1ll生
WVそれl〜ノ r\//−++/
ぞれ表わす。
化合物pHaの2つ異性K(C;6−αH及びβH)は
preparative TLCによりそれぞれ分離し
てから、’H−NMRkaJ定した。結果を第4表に示
す。
ビタミンD3窮導内と本発明試薬(化合1111G)と
の付加物である化合物rvb、rvc及びl′Vdの混
/++/ /2−ノ −−一ノ合液につ
いi、1−iPLcによる分離な次の条件で行なった。
HPLC分離条件
カラム: Li chrospher 10CIRP−
18f81 (5μm)4gm8250g+
#離削:【@線的勾配浴嘔による】
0分 水:メタノール=40:60′50分汝 水
:メタノール=20:8040分後 水:メタノール=
20:80流 速=11E//分
検 出: EX、37Qnm、Em、44Qnm。
IVd(−15nfP):l/10μtzり/−ル結果
な第2図ニ示す。図中、IVb、IVC,IVdど一ノ
/1Nノ ノアーノ
れそれ表わす。
以下に本発明化合物とビタミンA類との反応例について
説明する。
螢光注水ジエン試薬とビタミンAp導俸との反応(実施
91J8〜10)
1)=Y= −0H201−12
11A (22!、50μm06)のDMF溶Q(2m
+/)にPhI(OAC)2 (I61+19.50μ
moz)Y加え室温で30分撹拌し、IA?調製する。
この溶液Yrettnoic acid (I[]al
、 33μmot) 17)C)12Gt2 (20
aj)溶NKO℃Ar気流下滴下する。Q℃60分浸溶
媒を留去し、シリカゲルのT L Cテ10 % M
e OH/G HCZ 3 を用イ1aH’T247
.218hm、 IR(KBr)1770 。
1719 、1655clR−1
′HトMRCCDGL3)61.05及び1.14(各
々5H,& 、Me−1)、1.75(3H,s 、M
e−5)。
1.81(3)1.s、Me−9)、2.21 (3f
(、s。
Me−13)、3.73(6H,s 、NM6)、3.
94及び4.04(各々3H、a 、 OMe) 、
4.85 (Ih。
t、、H7)、4.85(IH,d、J=8.6.H−
10)、5.47(IH,a、、H−8)、5.83(
IH,t、H−14)、5.45(2H,s。
0−OH)、6.021)1.dd、J=15及び8.
6.H−11)、6.47(IH,d、J=15゜H−
12)、6.67及び7.37 (each I H、
s 。
キ/1r4jす7)、7.55及び7.58 (eac
h2 H。
AA’ BB’ 、 J=9 、 Ar )(9
0fNf’J9 ) とl ミyA酸(E6tinOi
CaCid)(26)とを、との反応
の溶液にPhI(OAc)2 (7,8mW、24.g
mot)を加え室温で30分撹拌し、1cの淡赤色溶f
f!Lな―製する。Fletinoic acid (
3−5III 、 12 pUaOL)のCH2Cl2
(I0m/)浴液に上記比の酸液な0℃にて加えAr
気流下60分間撹拌する、爵媒ヲ餉去し残#tなシリカ
ゲルのTL、Gで10%MθOH/C:H2Gt2 に
て精製し、付加陣Qb(5!。
66%)を得る。
Vb UV(95%EtOH)368,244.213
nmr−ノ
IFl(KBr)1771.1715.1649z−1
M8 m/8646CM”−1)、601,399.
355/HNMR(CDCl2)δ0.88及び0.9
5(各々3H、s 、Me−1)、’L59 (3H、
s、Me−5)。
t77(3H,@、Me−9)、2.19(3H,r、
。
Me−13)、!1.67 (3H、@、NMe)、3
.93及び4.01(各々”ki、s 、OMB) 、
4.61(IH,@、H−7)、4.74(IH,d、
J=8.6.H−10)、5.37(IH,s、H−8
)。
5.86(IH,i、H−14)、5.96(IH。
dd、J=15及び8.6 、8−11) 、 6.3
5(IH。
d、J=15.)i−12)、3−2及び4.0(各々
2H1m 、−0H20H2−3
込の反応
tlA (I5mg、 35.amOL)より調製した
IA17)DMF溶液f retinol (24)
(I Qll 、 35 pmot )ノOH,C;t
2(2051/)溶液に一78℃で加え、60分撹拌す
る。溶媒留去flk残渣をシリヵゲA/17)カラムチ
A OOE t / G HCZ a / E t O
f(5Q :50:1な溶媒に用いて精製し、付加体v
l(I49,55%)を得る。
化合物V+:
IR(KBr)3440.1771.1711.165
5ffi −”
/HNMR(GDC,t3) 0.992及び0.98
7(各々6H,s、Me−1)、 t66(5H,s、
Me−5)。
t99c5H、s 、Me−9)、1.91 (3H
、s 。
Me−13)、3.74(3f(、s、NMe)、19
5及び4.05(各々3)1.a、OMe) 、5.5
6(IH,dd。
J=8及び4 、OH、D、0ffi7FO消失) 、
4.24及び3.87(各々IH,rn、H−15)、
4.44−(IH。
(I,J=6.8−14)、5.22(I8,d、J=
凱H−10) 、5.31 (I H,m、H−11)
、5.70(IH,m、H−12)、5.99(I)
1.d、J=16.5.H−8)、6.17(IH,d
、J=16.5゜302.220
発明の詳細
な説明したように本発明により合成した螢光もしくは化
学発光試薬はC15−ジエンな持つ化合物と速く特異的
かつ定普的に反応する。従つてこれらの試薬はcps−
ジエンを持つ化合物、待にビタミンD、Aおよびそれら
の代謝物の検出、定量分析に適している優れた試薬であ
るということができる。【Gave. 'H-NMR (DMSO-d6)+5:5.21 (
2H1br, s, NH2) 6.60 and 6.97 (
4H1AA'BB'. J = 8.6 Hz, aroma H) 10.14
(2H, br, s, 2xNH) (I!! Example 7) C, tAAN=Q=Q −+01AANH−n HNH
■OEt3-chloropropyl isocyanate (5,C
1°4't, smmoz) of anhydrous benzene solution (I20
a/) to ethyl carbazate (5,2SF, 5α2 m
The mixture was heated under reflux for 1 hour. When the solvent was distilled off under reduced pressure, a crude product (9,25?) was obtained in crystal form, which was recrystallized from a single piece of AcOEt-gt,o.
Pure semicarbazide 7C1>59t)'l was obtained. lh
Crystal mother solution (2,24Pl' silica gel column chromatography 4- (Wacogel G-200, I0Off
) at! 1liL. Further Z(5
17av) was obtained. The total yield was 76.0%. Compound 7: mp 107.0-108.5°C MS m/Z (% Ri: 225 (M”+2.0.08)
, 223 (M”0.2), 178 (2), 180 (0,
7). 1721 and 1649 (C = 0) 'H-NMR (CDCl2) δ: +29 (3H, t, J = 6.9Hz, OH, 0H3
)2.00 (2H, m, 0H20H20H,)
&39 (2H,m, -OH,NH-)3.5
9 (2H, t, J=5,8Hz, CtCH2-)4
.. 21 (2H, q, J==6.9Hz, OH, OH
,) 5.68 (IH, m, NH) 6.76 and 6.81 (respectively I H, br, s. 2XN) l) (I!! Preparation Example 8) cz/XAsH-c-NHsHcoogt + semicarbazide 7 (5,256F, 23.5mmoz)
Anhydrous DMF# solution (55Nt) KNaN3 (I830P
. 28.2 mmoz) k was added and heated at 100°C for 6.5 hours. The mixture was heated and stirred. DMF%: Distilled off under reduced pressure, and water (5%) was added to the residue.
0a/) and extracted with AcOEt (5x70m/)K. The combined Ac0Et # is washed with water, dried with sodium chloride, and L! By solvent distillation, the crude azide group 8 (5,131 yield 9
468%] was obtained in crystalline form. Noble crystals were obtained from the main ether, and colorless crystals (&6C1) were obtained. Compound 8: J) 81-82°C MS m/Z (%): nom-185(2), 141
(3). 116 (2), 104 (I00) 2102 (N3) 1764 and 1671 C0 = 0) 〆) 1-NMR (GDC; t3) δ: t29 C3H0t, J = 7.5Hz, 0H20H8
)t80 (2H0m, 0H20H2C) (
2) 3.35 (2)1. II+, -0H
28H-)3.37 (2H, t, J=6.6Hz,
N30H2-)4.21 (2H, q, J=7.3H
z, CH20H3) 5.64 (IH, m, NH) and 66 and 6.73 (each tr IH, br, s. 2xNH) (Production Example 9) and anhydrous EtOH (I40d) were heated to reflux 6 I did it for an hour. EtOH was distilled off under reduced pressure, and water (50%
wLl)'Ik was added and made # acidic with 2NHC; t. 0) @Majesty's water layer should be adjusted with water in advance.
I passed it. After washing Arum with water (750117). Formed 'm11K: was desorbed and eluted from the resin with MeOH. The combined MeOH eluate * mountain part was distilled off to obtain a crude crystal product, which was recrystallized from 9I'AOOEt to give pure 9
(2,58P, yield 898%) was obtained as colorless flakes. Compound 9 m9140-141°C MS m/z (%): noM", 141 (20
), 129(39). Azide body 8 (5,6c1.15.6 mmot), crushed anhydrous potassium carbonate (2,60?, 18.7 mm
ot)1667(C=O)')(-NMR(DMSO-d6)δ:1.78 (
2H,quirltet,J=6.6Hz. -CH2C20H2-) 3.38 (2H, t, J=6.6Hz) 3.43
(2H1t, J=6.6H2)10.06 (2)
1. br, s, 2xNH) (Production Example 10) Azide tK9 (t7(In, 9.23mmoz)
vEtOH<191Lt) and H,O (7,5m/)
The mixture was dissolved in K and subjected to atmospheric hydrogen catalytic reduction in the presence of 10% pa-C:(I77ag). Ni! 1 reaction solution after carrying out the reaction for 96 hours. It was thoroughly removed through Celite. When liquid F is removed under m pressure, a crystalline residue (I, 6291) is obtained, and H, O
- When recrystallized from MeOH, free amino acid 1,0 (tO
O7F, yield 690%] was obtained as colorless needle crystals. Compound 10 J) 227-229°C 129 (47), 101 (95), 56 (94). 'H-NMR (D20) δ: 2.00 (2H, m, -CH2 to H20H2-)3
.. 03 (2H, t, J=Z4Hz, 0H2NH2)
3.60 (2H, t, J = 6.6H2, -C
H2-N) Salt of Compound 10 #I1. Salt azide form 9 (I40Iv, 0.76 mmot)'
kEtO)i (20m) and -dissolved in hydrochloric acid (0,4d) in the presence of 10% pd-C(305i&), 3.0
Medium pressure catalytic reduction was carried out at 2 h/on hydrogen pressure. After 4 hours at Tomitsu. When the reaction is complete and treated as above, 10 ml of HCl
The salt is obtained in crystalline form, MeOH-Et20! r)
Recrystallized pure 1 [IHCA salt (93, Omg),
Yield: 63.0%] was obtained as colorless needle crystals. MS m/z<9! o): 158 (M”, 100), 1
41 (50). Dinitroveratrol 11 (2,28F, 10m
mot) vm was dissolved in warm EtOH (,100a/). Catalytic reduction was carried out in the presence of -2Pω2(0,23)) at room temperature and in a hydrogen stream at normal pressure. After 2365 hours of stirring, the consumption of hydrogen completely stopped (theoretical hydrogen consumption: 1.3 t), so the reaction was terminated. The reduced product was quickly passed through a celite catalyst under a stream of phonemes, and the catalyst was removed, and the F solution was directly introduced into a reaction vessel in which dietherketomalone (I741, 1() mmot) had been previously placed. The reaction mixture solution was immediately heated under reflux for 1 hour and then left at room temperature overnight. Collect the precipitated crystals by suction. Crude crystalline product 12 (2,11?, yield 75.8%) was obtained. Recrystallization was performed from EtOH-OH20t2 to obtain yellow-green needle crystals (I98P). On the other hand, crystal F liquid (0.80t
] is silica gel column chromatography (4Fl)
From the CHC63 eluate containing 1% MeOH,
Furthermore, 12(0,33)) was obtained, with a total yield of 840%.
Met. Compound 12 mp250-251°C (Lit, 255°C) MS m
/Z (%): 278℃M, 100), 233(7)
. 'H-NMR (CDO13+CD30D) δ: 1.48
(3H, t, J=ZO)12. C1H2C)i3)
3.99 and 4.06 (each5H,s,2xO
CH3) 4.56 (2H, q, J=ZOHz, CH
2CH3) 6.94 and 138 (IH, s, a respectively
romH) (literature) z, 5uaesinsky a
nd A, Valenta. Co11ection Czechoslov, Che
m.Commun. 36.2527 (I971) (Production Example 12) NaH(0,26), 1197mm0t) anhydrous DM
12 (2,035', 7.31 mmot) of anhydrous D.
The MF (60at) solution was added over a period of about 20 minutes. After confirming that the generation of hydrogen gas had ended and the color of the solution had changed from yellow to tan (about 20-30 minutes), methyl iodide (0,68id, 1αq7mmot) was added dropwise over about 5 minutes. The reaction mixture solution was further stirred for 15 hours under water cooling, and then poured into ice-cold water (I50IL1).
15QMl). GHGt, the extracted layer was washed with saturated sodium chloride at °C and dried with mirabilite. The solvent was evaporated to give a yellow residue ac2.74t)k. Unproducts were analyzed by silica gel column chromatography (I30)
), GHGt3: Benzene (I
:1; v/v) From the elution part, 0-methyl compound 14 (0,1
0? , yield 4.7%] as pale yellow crystals. In addition, N-methyl form 1 (I, 7
2F. It was obtained as yellow crystals (yield: 80.4%). N-methyl compounds 1 to 6 were recrystallized from EtOH-Et, O to obtain yellow needle crystals, and 1 was gt, on-Hexane J
: It was recrystallized and pale yellow needle-like crystals were obtained. Compound 16 m9166-167°C MS m/Z (%): 292 (M, 100), 27
8 (I1). 277 (I2), 247 (I6), 220 (45),
205(6), 192(22). 'f(-NMR(CDC63)δ: t44 (3H, t, J=7.0Hz, 0H2(J,
) 3.73 (3H,s,N-0H3) 3.94 and 4. C5 (each 3B, 6°2xoca,) 4.51 (2H, Q, J=7.0Hz, OH, 0H
3) 6.71 and z56 (each IH, s, a
rom) i) Compound 14 mp123-125°C MS m/Z (%I): 292 (M”, 100), 2
47 (I6). 220 (45), 205 (I8), 190'H-NMR
(C;DGt,)-2t46 (3H,t, J=8.QHz, 0H20H,
) 4.00, 4.06 and 4.16 (each
5H. S, 3xOOH,) 4.52 (2H, q, J=8.0) 1z, 0H20
H8) 7.10 and 7.41 (6aChIH,S,
&rOmH) Elemental analysis: Calculated value measurement WL: Solution (51) was added and stirred for 10 minutes at room temperature.The reaction solution was converted to weak fIR using INHCz, and then cHat. The combined CHC layer was washed with water, dried with mirabilite, and the solvent was distilled off to obtain crude yellow crystals of carbon al15 (Q, 31°, yield 90.7%). The product was recrystallized from CHCL3 to obtain yellow needle-shaped crystals. Compound 15 mp241-243℃ (Lit, m9222℃) MS
m/Z (%): 264 (M”-27)-220 (I00
) - (Reference) T, Iwata, M, Yamagu
chi, S., Hara. M, Nakamura, and Y, Ohkura. J, Gchromatogr., 362.209 (I98
6) (Production N14) υ and N-methyl form 13 (D, 48t, t63mmo4
) 1,4-dioxane (5m) solution 11CIN
NaOH aqueous p-rubonic acid 15 (470m9.178m
A mixed solution of moz ) and 5OCz, (I0m ) 1
The mixture was heated to reflux for an hour. Under reduced pressure, excess 5OCz 2%: @i
The reddish brown crystals obtained were recrystallized from anhydrous benzene-n-hexane to give acid chloride 16 (43
5Iv. Yield: 86.6%]. Compound 16 mp 272-275°C (decomposition) [Lit, mp26
1℃] MS m/Z (% Ri: 284 (M”+2.21)
, 282(M”, 62). (Reference) T, Iwata, M, Yamaguch
i, S, Hara and M, Nakamura, J.
Ghrormtogr, 362. (Example 1) Acid chloride 16C113jlS', 0.4mm0L)
Dissolved in fk anhydrous benzene (8WLt), stirred and refluxed the solution, and added benzyl alcohol group 3 (I24~, 0.
6 m mot) of anhydrous DMF' (Q, 511+17)
The solution was added all at once and the reflux was continued for 15 hours. A yellow precipitate began to form upon addition of 6. The reaction solution was cooled to tO°C, and the precipitated crystals were collected by suction and washed with benzene. The yellow crude crystals (I84~) were swollen with chloroform and subjected to Sephadex LH-20 column chromatography.
CHCt3 containing 5% MeOH
[13 [10311 g, yield 56.8%] was obtained from the eluate. This product was recrystallized from MeOH-CHC; t3 to obtain yellow crystals. Compound iIA mp 279-280°C (decomposition) MS (+SIMS) m/z: 454 (M"+1)'H-
NMR (CDC63+DMSO-d,) J:'5.75
(6H,s,N-1c)I3) 3.92 and 4.0
5 (3H, s, 2xOCH, respectively) 5.43 (
2H, s, OH2ph) 691 and Z36 (41 each
H, s, arom H) 7.54 and 7.58
(4H, AAJ3B'. J=8.6Hz, aromH. 10.56 (2H, br, s, 2XNH) Elemental analysis: Total 'lI1. value (C2□H1gN50.) OH30H: C, 54, 43
; fi, 4.78; N, 14.45 measured value
: C, 54,42; H, 4,35; N, 14.8
3 (Example 2) Liquid %: After returning to room temperature, the precipitated crystals were collected by suction, and a jk color crude crystal product [IB (I1,3, yield 55.1%)] was obtained. The main island is extremely Jk11i!
As a note, it is used without purification in the following reactions. Compound 11B'H-NMFI (DMSO-d6)-2 3.78
(3H,s,N-OH,)6.89 and 4.03
(3H, s, 2xOcH3 respectively) Zlo and Z47
(respectively I H, S, MOm H) 7.45 and Hif,
85 (4H, AA'BB'. J = 9.0f (z, arom H) 10.42 (2H, 8, 2XNH) (Production Example 15) Acid chloride 16 (20jllf, Q, 07mmoz)
To a refluxing solution of anhydrous benzene (2,5id), 6 (
91111F, 0.047 mmot) anhydrous DMF
(0,1d) solution was added all at once and the reaction mixture was heated for 1 hour. Reacted dinitroberatrol 11
(0,91?, 4 mmot) in EtOH (80
d), catalytic reduction was carried out in the presence of Pto□ (89#) at room temperature in a hydrogen stream at normal pressure. The reaction continued for about 17 hours until hydrogen consumption (theoretical consumption 154,017) completely stopped. The resulting pale yellow-green bath liquid was passed through celite in a kiln gas stream to remove the catalyst, and the tF liquid was saturated with 2-ketoglutaric acid (
The mixture was collected in a reaction vessel containing 0.58y, 4mmoz) and immediately heated to reflux. 1 reaction after 15 hours? :P, done. When the reaction solution was cooled, orange-yellow crystals were precipitated. The precipitated crystals were suctioned and quinoxalinone 17 (0,8
0), yield 71.9%], which was fluorolysed from EtO) to give yellow needle crystals (0,62) 1-. Compound 17 mp250-252°M3 m/z (%ri: 278 (M”, 36)
, 260 (I00). 232 (88n, 217(32), 189'H-NMR
<CDC; t3) a: 2.80 (2H, t, J
=7.5Hz, -0H2Co-)3,ts (2H,t
, J=7. sHz, 'cH-) 3.92 and 3.93 (
3H, s, 2xOCH3) 6.78 and 118 respectively
(1H, S, 2LrOmH, respectively) 11.92 (I
H,br,sig,-C;0OH)18 El2G0
0CH8 20h=cooH Method I> Ice-cold NaH (I76W, 7.3mmoz) o>
Add compound 17 (6) to a suspension in anhydrous DMF (3a()) with stirring.
06 Satoshi, 2.2 mm06) f) Anhydrous DMF (20
m) Leave the solution for about 20 minutes. FLK
Stirring was started at 0.514 °C.Next, the reaction volume 1i
FK methyl iodide (455pi, 7.3mmot)
K was added dropwise over about 10 minutes, and the entire reaction solution was then heated to 0.
Stir for 15 hours at <0>C and pour into ice-cold water (50m). Mixed bath liquid. The organic layer was washed with saturated brine, dried with sodium sulfate, and the solvent was distilled off. A crude product (570 my) was obtained. This is the main structure. Silica gel column chromatography (Wacogel
Purified with G-200, 24)), n-Hexane
:Ac0Et (4: 1-2: 1; v/v
) ty> N-methyl form 18 (492 mg
, yield 73 o 8%) was obtained and recrystallized from MeOH-cHct3 to obtain pale yellow needle crystals. Only a trace amount of 0-methyl compound 19 was obtained (see Method I). On the other hand, the aqueous layer after CHO6 extraction was made acidic with Q,5NHC6, and then re-extracted with GHC13 containing 5% MeOH, and the organic layer was washed with saturated brine, dried with mirabilite, and the solvent was distilled off. Carboxylic acid 20 (86 cm. 13.5%) was obtained in crystalline form. Main island fMeOH-c
Recrystallization from Hct3 gave yellow needles. Method l> Carvone [17 (t00?, 3.60 mmoz)
%: OH, OL, -MeOH (I: 1: V/V
, 100WLt) K& was made cloudy, and diazomethane ether bath solution V was added to the solution under stirring at room temperature until 17 of the raw material V disappeared. Excess diazomethane is distilled off using a rapid accumulative air stream, and then 1 kftj of the medium is removed under reduced pressure.
N) was obtained. This product was purified by silica gel column chromatography 4-(Wacogel C;-2[]0,5
Qf) Made of K shaft, n-Hexane: Ac0J? :
O-methyl compound 1 from the t(6: 1; V/V) elution part
9 C48011jf, yield 43.6%) and n-f
(exane: Ac0ji: t (I: 1 ; v/v
) N-methyl compound 18 (5281Iy, yield 48.0%) was obtained from the eluate. The 0-methyl body 19 is NaOH-CHOP3! The crystals were recrystallized to obtain colorless prism crystals. Compound 18 mp174-175°C MS m/z (%): 306 CM”, 100), 2
74 (I5). 258 (I4), 247 (88), 231 (24)
, 203(20) Br IRymaX5++-1:1740 and 1651 (C
=0)') i-NMR (CDCj3) δ: 2-86 (2)1. t-J=ZIH2-CHzGO
)3.25 (28,t, J=ZIHz, )-a)C
2-]6.69 and 3.70 (respectively 3H, S, N-
CH3゜C100CH3) 6.96 and 4.01 (3H,s, 2xOCH respectively
3) 6.68 and 125 (IH, s, aromaH, respectively)
) Compound Th19 mp 137-169°C MS m/z (%): 306 (M”, 51), 27
5 (I0). Compound 20 ml) 239-241°C MS l/Z (%): 292 (M”, 533.2
74(99). 246 (I00), 231 (53), 203 (41),
175 (27) Br IRymaXa*-”: 1764 and 1628 (0=
0)') 1-NMR (DMSO-d6) δ: 2.70
(2H, t, J=6.9Hz, 0H2CO) &00
(2H, t, J=49Hz, 0H2082Go)6-
65 (3H-s -N -G Hs ) 584 and 5.94 (6H, s, 2xOCH, respectively) 6.9
8 and 122 (IH, SlrOmH, respectively)')l −
NMR (C; DC, C3) δ: 2.89 (2H, m
) 3.24 C2H,m) 3.71 (3H0,s,C00CR,)4.00 and 402 and 4.07 (3H.,s,5xOC;H,) 7.17 and 7.27 (eachll( ,s,aro
mH) 18 2O N-methyl form 18 (tl 513.75 mmoj
) tl, 4-shi:ir*ty (I8su) and IN NaOH7jC solution (IDia/)K dissolved,
The reaction was stirred and reacted for 10 minutes under N temperature. The reaction mixture contains dilute salt t
After it is acidic. Extraction was repeated with cHct containing 10% MeOH until the bottom of the aqueous layer disappeared. The combined organic layer is The crude crystalline carboxylic acid 20 (I, OFl, yield 95.9%) was obtained by washing with saturated saline, drying with sodium sulfate, and distilling off the solvent. Motojima was recrystallized from MeOH-Of (Cz3). Pure product 20 (852~) was obtained, which matched the compound !1120 previously attended. (Production Example 18) Carboxylic acid 20 (500 Iv, 171 mmot)
t' Dissolve one bottle of anhydrous DMF (I2jl/)K and add triethylamine (0.36wr!, 2.57 m) to the stirred solution.
moz), phosphoric azide (0,55
ml, 2.57 mmol) was then added dropwise. After 1 hour of reaction, diphenylphosphorus e17)” (0,54
mmot) k, stirred at room temperature for 15 hours, #! Yellow-yellow-green liquid liquid. The bath was immediately removed under reduced pressure and the residue was dried under high vacuum. Anhydrous pensene (2011J)' was added to the dried product, and the mixed solution was heated under reflux for 1 hour. After the reaction solution was returned to temperature, carbazic acid ether (I78m&t711 [1m0t) was added. The reaction solution has M of 0.5
After refluxing IWl for a while, stir for 0.5 h under humid M. #
an-distilled. Obtained pale yellow residue aC1,976t)
teeth. Purification was performed by silica gel column chromatography (91:l), and semicarbazide 21 (230m9) was obtained from the eluate of CHC43 containing 4 to 5% M80H.
P) In addition, 21 (I64 mg) was obtained with a total yield of 58.6%. Compound 21 MS m/Z (%): 393 (M”, 5), 347 (0
, 8). Ro 30 (I), 289 (92), 246 (47). 'H-NMR (DMSO-d,) δ: 1.18 (3H,t, J = 6.9Hz, 0H2C
H3) 2.95 (2H, t, J=5.9Hz, CH
20H2NH-)3.52 (2H,m, CH,
NH) 167 (5H,s, N-CH,) 3.89 and 3.97 (3H,s, 2xOCH, respectively
3) 4.02 (2H, Q, J=6.9Hz, (H2
0H3)6.40 (IH,br,sig,NH)6
.. 91 and z31 (IH, S, lLromH, respectively) 7
.. 70 (IH,br,s,NH)8.65 (I
H, br, sig, NH) semicarbazide 21 (272
~, 0.69 mmot). Anhydrous potassium carbonate with stopper frame (I91~, i8mmot)
The mixture was heated under reflux for 6 hours in a bath of abs EtOH (20 ysi). The solvent was distilled off under reduced pressure, and the remaining aK water (60
In addition to Muri', it was made acidic with 2NHC6K. water 1164
! , 10%MeO)1 *OHC; t3(3x50
au) Extracted with K, the organic layer was washed with saturated saline,
After drying and evaporating the solvent, pale yellow crystals (4 g of 222I) were obtained.
) was obtained = MeOf(-Crystalized from CHCL3,
90(I30%') 9 was obtained as yellow prism crystals. The crystal mother liquor (70 mg) was purified by silica gel column chromatography (I (I), and purified with 5% MeOH-containing G
HGt3#a[SC') further t/Cr1OC64119)
The total yield was 80.8%. Compound-C ml) 250-255°C MS Vz (%): 547 (M”, 5), 289 (
2). 246 (I00), 231 (35), 205I
RymaXa*-1:1694 and 1640 (C=0)
'H-NMR (DMSO-d6) δ: 3.02 (2)1. t, J = 6.9Hz. 3.65 (3H,s,N-0H3)3.80 (
2H,t,J=6.9Hz. 3.84 and 3.95 (3H, 8, 2XOCH respectively
3) 6.96 and Z26 (lH, s, aromaH, respectively
)9.95 (2H,S,2XNft). (Example 5) Triazo') Schiff IC (IQ, Qap, 0.
029mmot) in anhydrous DMF (Im) solution was added PhI (
OAc), (I12~, 0.035 mmot) 9 was added, and the mixture was stirred at room temperature for 1 hour. Removal of DMFlk under reduced pressure gave a red solid residue. Main island v cH2at2-
When benzene was crystallized, red prismatic crystals of the desired IC were obtained, although the amount was very small. the current,
Methods (sublimation method, etc.) to obtain pure products in large quantities are currently being considered, including amino acid (98 mm width, 0.05 mmot) and coal plate potassium (I5.2 mm, 0.11 mmot). 7-chloro-4-nitropenzofurazane (8,34', α041 mrnol) in aqueous solution (0,25 m)
The tOH(I-) solution was added over about 5 minutes. The resulting dark purple solution was stirred at room temperature for 10 minutes and then heated to 60-70°C.
The mixture was heated and stirred for 5 minutes. Dark purple reaction suspension solution. When acidified with 2NHO1K, a dark red solution was obtained. The solvent was distilled off under reduced pressure, and the residue fi (44,5~) was obtained. It was produced using ODS column chromatography (WaterS Co., ODS packing material for dispersion 5?). The column is 2
Elute with water containing 0% MθOH, triazolidine tl
DC9.5~, yield 70.9%] was obtained as a yellow-red sticky substance. Compound [ID Br IRνmax cm-”: 1688 (C=0)
1586 and 1301 (NO,) MS l/Z (%): noM'''H-NMR (DMSO-d,) a: t99 (2H, m) 54-&5 (4H, m) 6.42 (I) 1.d, J=9.2Hz, aroma
H) 851 (IH, d, J=9.2Hz, aroma
H) 9.42 (If(0m, Nf() IQ, 10 (2H,s, 2xNH) (Actual #ilI Example 6) fiE O N-methylacridinium (22~, 0.038m m
ot) 17) Anhydrous DMF (0.5 mg) il:7
t/JinU C7,6Iv, 0.048mm06l- was added, and the resulting reaction suspension was heated and stirred at an external temperature of 50-60°C for 6 hours. DMF was distilled off under reduced pressure, leaving a dark yellow residue (43,
An aqueous hydrochloric acid solution (an amount corresponding to 0,057 mmoz of hydrogen chloride) and MeO) were added to the remaining solution. The solvent was distilled off again, and the residual Sephadex LH-2 [
1 column chromatography (551) and moxibustion. Fill the column with 1 ml of EtO. Elution was performed with EtOH. Elution volume 67-46d yellow fraction thlt collected compound rJEc22.4■, yield 94
.. 8%). Compound lIE 'H-NMR (DMSO-d6) δ: 167 (2H,m, -HNCH,CH2O) (2-
)2.46 (2H,t,J =7.3Hz,-()
12G-)2.94 (2H0t, J=7.6Hz,
Ph0H2-)3.06 (2H,m-
HNCH2-)5.36 (2H,t,J=6.6f
(z, -0H2N)4.97 (3H,s,
10N-CH5) 746 and 7.65 (
4H, AA'BB'. J:8.6H2, aromH) 7.92 (IHom, NH) 8.19 (2)1, m, aromH)
8.57 (2H, m, aroma H)8.6
2 (2H, d, J=8.6Hz, aromJ8.9
6 (2)1. d, J=9.2Hz, aromaH)1
0.10 (2H, br, s, 2XNH) Below, an example of the reaction between the compound of the present invention and vitamin Ds will be explained. (Example 7) am R1=R2=Rg=H b= R1=R3=HR2=OH C=R□:OHR2,F13=f(d:R,=R2=O)I R3=He=R1
=R3=OHR! =H Method 1) Oxidation of one area with Pb(OAc)4,
Continuation of bow, A, reaction Vl tamtn D3 22 a (91W
, 0.0 2 4 mm01)L[I A (I
2.9W, 0.028mmot), anhydrous DMF (0
, 2d), anhydrous THF (0,3id) and g4. A.C.O.
A suspension of H (5 μt) was cooled to 75°C and stirred with one tube of Pb(OAc), (I8.9 mg, 0.043 m
mO/-) was added. The reaction suspension was PbC0Ac)4
Five minutes after the addition, the mixture turned red. The reaction solution was heated for 1 hour-7
After stirring at 5°C, the mixture was returned to room temperature and the reaction was continued for an additional hour. Pour the reaction mixture into ice-cold water and add cHct3 (3X1
5awj)K and extracted. The cHat 3 layer was washed with saturated saline, dried with Glauber's salt, and the solvent was distilled off. Obtained yellow sticky substance (22, [3W)
veTLO (Merck company lit, 5ilica
gel 6OF254゜20 tx (W) X I
Q cm (H) X O,5am (T) !C6-αH] (G, -βH: 1.6#) 'i' was obtained. The total yield was 555%. and apricot crystallization from MeOH-C; H2O12 to obtain yellow needle-like crystals. Compound-a (G6-αH) mp 145-145°C UVλIJQHnm (log g): 217 (4
, 72). 24 (Shoulder), 322 (3,80). 4ON4.07). Elemental analysis two calculated values (048H61N5011-Hρ): C, 67,50
:H, 7, 45: N, 8.20° 11J constant 11
:C,67,08:)1.7.18;N,8.12
゜<Method 2> PhI (OAc) 2 and 11A4)
Oxidation, iJ followed by reaction with vitamin D (Iid) FItK, PhI (OAC), (7,
5av, 102!1mm0A)t' was added, and stirring was continued at room temperature for about 0.5 to 1 hour until the first reaction solution developed a sufficiently red color. This red solution D, 24.25 (OH), D, 22e (
5, Oav. 0.012 mmOL) was added thereto, and the mixture was further stirred for 5 hours until the red color of the solution disappeared. The solvent was distilled off under reduced pressure. A member-colored adhesive substance (24,1~) was obtained and prepared.
ativeTLCC Merck H5ilica ge
l 60 F2. . 20cm (W) X 10m (H) X O, 5aa*
(T)
L2) was purified at °C and a mixture of adducts c6-αH anti-βh, 10.4 μm. It was obtained as a non-crystalline a'R colored adhesive powder (yield: fixed). Table 1 shows the differential production ratio and yield of the adduct of vitamin D and the reagent of the present invention obtained in this way. Compounds 1c, ld and Ie are mixed
The r-no-liquid was analyzed by HPLC (high performance liquid chromatography) under the following conditions. HPLC separation conditions A: Li chromospher 10CIRP
15lel (5,czm)4 aa X 250
m #* Agent: Water: Methanol = 27: 73 (v/v
) Flow rate: 11/min Detection 2 EX395nm, Em500nm6nP))
/10 μt ethanol results are shown in FIG. In the figure, lc, l (I, let etc.N) l\no l-1/ is the main production ml Ic', tumor d'0zene' is l1ll raw WV it l ~ no r\//-++/ represents. The two isomers K (C; 6-αH and βH) of compound pHa were separated by preparative TLC, and then 'H-NMRkaJ was determined. The results are shown in Table 4. Mixture of compounds rvb, rvc and l'Vd which are adducts of vitamin D3 and the reagent of the present invention (compound 1111G)/++//2-no--1-iPLc separation using i, 1-iPLc It was conducted under the following conditions. HPLC separation conditions column: Li chromospher 10CIRP-
18f81 (5μm) 4gm8250g+ #Removal: [@By linear gradient bathing] 0 minutes Water: Methanol = 40:60'50 minutes Water: Methanol = 20:80 After 40 minutes Water: Methanol =
20:80 flow rate = 11E//min detection: EX, 37Qnm, Em, 44Qnm. IVd(-15nfP): 1/10 μtz/-L The results are shown in FIG. In the figure, IVb, IVC, and IVd are represented by 1/1N. Examples of the reaction between the compound of the present invention and vitamin A will be explained below. Reaction of fluorescent water-injected diene reagent with vitamin Ap injection (Execution 91J8-10) 1) = Y = -0H201-12 11A (22!, 50 μm06) in DMF
+/) to PhI(OAC)2 (I61+19.50μ
moz) Y and stirred at room temperature for 30 minutes, then added IA? Prepare. This solution Yrettnoic acid (I[]al
, 33μmot) 17)C)12Gt2 (20
aj) Add the dissolved NKO dropwise under an Ar stream at °C. After immersing at Q℃ for 60 minutes, the solvent was distilled off and the silica gel TLC was 10% M.
e 1aH'T247 using OH/G HCZ 3
.. 218hm, IR (KBr) 1770. 1719, 1655clR-1'H to MRCCDGL3) 61.05 and 1.14 (5H, &, Me-1, respectively), 1.75 (3H,s, M
e-5). 1.81(3)1. s, Me-9), 2.21 (3f
(, s. Me-13), 3.73 (6H, s, NM6), 3.
94 and 4.04 (3H, a, OMe, respectively),
4.85 (Ih. t,, H7), 4.85 (IH, d, J=8.6.H-
10), 5.47 (IH, a,, H-8), 5.83 (
IH, t, H-14), 5.45 (2H, s. 0-OH), 6.021) 1. dd, J=15 and 8.
6. H-11), 6.47 (IH, d, J = 15°H-
12), 6.67 and 7.37 (each I H,
s. Ki/1r4jsu7), 7.55 and 7.58 (eac
h2 H. AA'BB', J=9, Ar) (9
0fNf'J9) and lmyA acid (E6tinOi
PhI(OAc)2 (7,8 mW, 24.g
mot) and stirred at room temperature for 30 minutes, and the pale red solution of 1c f
f! L-manufactured. Fletinoic acid (
3-5III, 12 pUaOL) of CH2Cl2
(I0m/) Add Ar at 0°C to the bath solution with the above ratio.
Stir for 60 minutes under a stream of air, remove the solvent, and purify the residue with 10% MθOH/C:H2Gt2 using silica gel TL and G to obtain the adduct Qb (5!.66%). Vb UV (95% EtOH) 368,244.213
nmr-IFl (KBr) 1771.1715.1649z-1
M8 m/8646CM”-1), 601,399.
355/HNMR (CDCl2) δ0.88 and 0.9
5 (3H, s, Me-1 respectively), 'L59 (3H,
s, Me-5). t77 (3H, @, Me-9), 2.19 (3H, r,
. Me-13),! 1.67 (3H, @, NMe), 3
.. 93 and 4.01 (respectively "ki, s, OMB"),
4.61 (IH, @, H-7), 4.74 (IH, d,
J=8.6. H-10), 5.37 (IH,s, H-8
). 5.86 (IH, i, H-14), 5.96 (IH. dd, J=15 and 8.6, 8-11), 6.3
DMF solution f retinol (24)
(I Qll, 35 pmot)ノOH,C;t
2 (2051/) solution at -78°C and stirred for 60 minutes. Solvent distillation flk residue is silicage A/17) Column A OOE t / G HCZ a / E t O
f(5Q:50:1 solvent) to purify the adduct v
1 (I49, 55%) is obtained. Compound V+: IR(KBr)3440.1771.1711.165
5ffi-”/HNMR (GDC, t3) 0.992 and 0.98
7 (6H, s, Me-1 respectively), t66 (5H, s,
Me-5). t99c5H, s, Me-9), 1.91 (3H
,s. Me-13), 3.74 (3f(,s,NMe), 19
5 and 4.05 (3 each)1. a, OMe), 5.5
6 (IH, dd. J=8 and 4, OH, D, 0ffi7FO disappearance),
4.24 and 3.87 (IH, rn, H-15 respectively),
4.44-(IH. (I, J=6.8-14), 5.22(I8, d, J=
Kai H-10), 5.31 (I H, m, H-11)
, 5.70 (IH, m, H-12), 5.99 (I)
1. d, J=16.5. H-8), 6.17 (IH, d
, J=16.5°302.220 DETAILED DESCRIPTION OF THE INVENTION As described in detail, the fluorescent or chemiluminescent reagents synthesized according to the present invention react rapidly, specifically and routinely with compounds containing C15-dienes. These reagents are therefore cps-
It can be said that it is an excellent reagent suitable for the detection and quantitative analysis of diene-containing compounds, especially vitamins D and A, and their metabolites.
第1図は、ビタミンD、各肋導陣と本発明試薬IAとの
付加体vHpLcにより℃分離した徽に検出した各々の
付加体のピークを表わすクロマトグラムである。
第2図は、ビタミンD3各誘導体と本発明試薬ICとの
付加体なt−1pLcによって分離した後に検出した各
々の付加体のピークを表わすクロマトグラムである。
特許出願人 株式会社バイオセンサー研究所代理人
弁理士 湯 浅 恭 三、: ’、−、’鬼I(外4名
)FIG. 1 is a chromatogram showing the peaks of adducts of vitamin D, adducts of various adducts, and the reagent IA of the present invention detected by separation at °C using vHpLc. FIG. 2 is a chromatogram showing the peaks of each adduct of vitamin D3 derivatives and the reagent IC of the present invention detected after separation by t-1pLc. Patent applicant Agent of Biosensor Institute Co., Ltd.
Patent attorney Kyozo Yuasa: ', -,' Oni I (4 others)
Claims (1)
を示し、Yはスペーサーを示す) で表される化合物。 2、一般式(II) ▲数式、化学式、表等があります▼(II) (式中、Xは蛍光発色団またはポテンシャル化学発光基
を示し、Yはスペーサーを示す) で表される化合物。 3、Xが下記式 ▲数式、化学式、表等があります▼ ▲数式、化学式、表等があります▼ は同一でも異なっていてもよく、水素原子またはアルキ
ル基を示す〕 で示される基よりなる群から選ばれた一員であり、Yが
下記式 −(CH_2)_l− ▲数式、化学式、表等があります▼ −(CH_2)_l−B−(CH_2)_l−(式中−
A−は−O−または−NH−を示し;−B−は、−NH
−、−COO−、−SO_2NH−、▲数式、化学式、
表等があります▼および▲数式、化学式、表等がありま
す▼よりなる群から選ばれ た一員を示し、 lは1から5までの整数を示し、 mは0から5までの整数を示し、 nは0または1のいずれかを示す) で示される基よりなる群から選ばれた一員である(但し
、Yのそれぞれの式の左端は環の窒素原子と右端はXと
結合する)、 請求項1または2に記載の化合物。 4、Xが下記式 ▲数式、化学式、表等があります▼ (式中Zは酸の共役塩基を示す) で示される基よりなる群から選ばれた一員であり、Yが
下記式 ▲数式、化学式、表等があります▼、▲数式、化学式、
表等があります▼ −(CH_2)_n− (式中nは0または1のいずれかを示す) で示される基よりなる群から選ばれた一員である(但し
、Yのそれぞれの式の左端は環の窒素原子と、右端はX
と結合する)。 請求項3に記載の化合物。 5、Xが下記式(III) ▲数式、化学式、表等があります▼(III) およびYが下記式(IV) ▲数式、化学式、表等があります▼(IV) で示される基である、請求項3に記載の化合物。 6、一般式(V) ▲数式、化学式、表等があります▼(V) または(VI) ▲数式、化学式、表等があります▼(VI) (式中、Yはスペーサーを示し、 Qはヒドロキシメチル基またはアミノ基を示す)で表さ
れる化合物を一般式(VII) X−COCl(VII) (式中、Xは蛍光発色団またはポテンシャル化学発光基
を示す) で表される化合物とカップリングすることを特徴とする
一般式( I ) ▲数式、化学式、表等があります▼( I ) (式中、XおよびYは前記の意味を有する)または一般
式(II) ▲数式、化学式、表等があります▼(II) (式中、XおよびYは前記の意味を有する)で表される
化合物の製造方法。 7、一般式(VIII) ▲数式、化学式、表等があります▼(VIII) (式中、Xは蛍光発色団またはポテンシャル化学発光基
を示し、Yはスペーサーを示し、WはC_1〜C_3ア
ルキル基を示す) で表されるセミカルバジド体を閉環することを特徴とす
る一般式II ▲数式、化学式、表等があります▼(II) (式中、XおよびYは前記の意味を有する)で表される
化合物の製造方法。 8、一般式( I ) ▲数式、化学式、表等があります▼( I ) (式中、Xは蛍光発色団またはポテンシャル化学発光基
を示し、Yはスペーサーを示す) または一般式(II) ▲数式、化学式、表等があります▼(II) (式中、XおよびYは前記の意味を有する)で表される
化合物を蛍光もしくは化学発光試薬として用いることを
特徴とする、化学構造中にCiS−ジエン構造を持つ化
合物の検出および定量分析法。 9、一般式( I ) ▲数式、化学式、表等があります▼( I ) (式中、Xは蛍光発色団またはポテンシャル化学発光基
を示し、Yはスペーサーを示す) または一般式(II) ▲数式、化学式、表等があります▼(II) (式中、XおよびYは前記の意味を有する)で表される
化合物を蛍光もしくは化学発光試薬として用いることを
特徴とする、ビタミンD、ビタミンAまたはこれらの代
謝物の検出および定量分析法。[Claims] 1. General formula (I) ▲There are mathematical formulas, chemical formulas, tables, etc.▼(I) (In the formula, X represents a fluorescent chromophore or a potential chemiluminescent group, and Y represents a spacer.) Compound represented. 2. General formula (II) ▲Mathematical formulas, chemical formulas, tables, etc. are available▼(II) (In the formula, X represents a fluorescent chromophore or potential chemiluminescent group, and Y represents a spacer.) A compound represented by the following. 3. A group where X is a group represented by the following formula ▲ There are mathematical formulas, chemical formulas, tables, etc. ▼ ▲ There are mathematical formulas, chemical formulas, tables, etc. ▼ may be the same or different and represent a hydrogen atom or an alkyl group] Y is a member selected from the following formula - (CH_2)_l- ▲ There are mathematical formulas, chemical formulas, tables, etc.
A- represents -O- or -NH-; -B- represents -NH
-, -COO-, -SO_2NH-, ▲mathematical formula, chemical formula,
Indicates a member selected from the group consisting of tables, etc.▼ and ▲Mathematical formulas, chemical formulas, tables, etc.▼, l indicates an integer from 1 to 5, m indicates an integer from 0 to 5, n represents either 0 or 1) (However, the left end of each formula of Y is bonded to the nitrogen atom of the ring, and the right end is bonded to X). The compound according to 1 or 2. 4. X is a member selected from the group consisting of groups represented by the following formula ▲ There are mathematical formulas, chemical formulas, tables, etc. (in the formula, Z represents the conjugate base of the acid), and Y is the following formula ▲ There are chemical formulas, tables, etc.▼,▲mathematical formulas, chemical formulas,
There are tables, etc. ▼ -(CH_2)_n- (in the formula, n indicates either 0 or 1) is a member selected from the group consisting of the groups represented by (However, the left end of each formula of Y is The nitrogen atom of the ring and the right end is X
). A compound according to claim 3. 5. A compound according to claim 3. 6. General formula (V) ▲ There are mathematical formulas, chemical formulas, tables, etc. ▼ (V) or (VI) ▲ There are mathematical formulas, chemical formulas, tables, etc. ▼ (VI) (In the formula, Y represents a spacer, and Q represents hydroxy Coupling a compound represented by the general formula (VII) X-COCl (VII) (in which X represents a fluorescent chromophore or a potential chemiluminescent group) General formula (I) ▲ There are mathematical formulas, chemical formulas, tables, etc. ▼ (I) (in the formula, X and Y have the above meanings) or general formula (II) ▲ Numerical formulas, chemical formulas, tables, etc. etc. ▼(II) A method for producing a compound represented by (wherein, X and Y have the above meanings). 7. General formula (VIII) ▲Mathematical formulas, chemical formulas, tables, etc.▼(VIII) General formula II characterized by ring-closing a semicarbazide represented by A method for producing a compound. 8. General formula (I) ▲ There are mathematical formulas, chemical formulas, tables, etc. ▼ (I) (In the formula, X represents a fluorescent chromophore or potential chemiluminescent group, and Y represents a spacer) or general formula (II) ▲ There are mathematical formulas, chemical formulas, tables, etc. ▼ (II) (In the formula, X and Y have the above meanings) The compound is used as a fluorescent or chemiluminescent reagent, and contains CiS in the chemical structure. - Detection and quantitative analysis method for compounds with diene structure. 9. General formula (I) ▲ There are mathematical formulas, chemical formulas, tables, etc. ▼ (I) (In the formula, X represents a fluorescent chromophore or potential chemiluminescent group, and Y represents a spacer) or general formula (II) ▲ There are mathematical formulas, chemical formulas, tables, etc. ▼ (II) Vitamin D, vitamin A characterized by using the compound represented by (in the formula, X and Y have the above meanings) as a fluorescent or chemiluminescent reagent. or detection and quantitative analysis methods for these metabolites.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2105046A JP2638253B2 (en) | 1990-04-20 | 1990-04-20 | Vitamin D quantification reagent and method for producing the same |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2105046A JP2638253B2 (en) | 1990-04-20 | 1990-04-20 | Vitamin D quantification reagent and method for producing the same |
Publications (2)
Publication Number | Publication Date |
---|---|
JPH045287A true JPH045287A (en) | 1992-01-09 |
JP2638253B2 JP2638253B2 (en) | 1997-08-06 |
Family
ID=14397059
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2105046A Expired - Lifetime JP2638253B2 (en) | 1990-04-20 | 1990-04-20 | Vitamin D quantification reagent and method for producing the same |
Country Status (1)
Country | Link |
---|---|
JP (1) | JP2638253B2 (en) |
Cited By (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2004002996A1 (en) * | 2002-06-27 | 2004-01-08 | Chugai Seiyaku Kabushiki Kaisya | Ferrocene compound and use thereof |
WO2009016841A1 (en) * | 2007-08-01 | 2009-02-05 | Kumiai Chemical Industry Co., Ltd. | Oxopyrazine derivative and herbicide |
EP2515914A1 (en) * | 2009-12-23 | 2012-10-31 | The Scripps Research Institute | Tyrosine bioconjugation through aqueous ene-like reactions |
JP2017537331A (en) * | 2014-12-08 | 2017-12-14 | エフ.ホフマン−ラ ロシュ アーゲーF. Hoffmann−La Roche Aktiengesellschaft | Method for measuring vitamin D |
JP2019214523A (en) * | 2018-06-12 | 2019-12-19 | 株式会社トクヤマ | Method for producing semicarbazide compound, and method for producing triazolidinedione compound |
US11034669B2 (en) | 2018-11-30 | 2021-06-15 | Nuvation Bio Inc. | Pyrrole and pyrazole compounds and methods of use thereof |
CN117417405A (en) * | 2023-12-15 | 2024-01-19 | 上海快序生物科技有限公司 | Peptide segment labeling method based on tyrosine derivatization and application of peptide segment labeling method in protein detection |
-
1990
- 1990-04-20 JP JP2105046A patent/JP2638253B2/en not_active Expired - Lifetime
Non-Patent Citations (2)
Title |
---|
J.MED.CHEM. * |
MOL.PHARMACOL.=1987 * |
Cited By (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2004002996A1 (en) * | 2002-06-27 | 2004-01-08 | Chugai Seiyaku Kabushiki Kaisya | Ferrocene compound and use thereof |
US7019146B1 (en) | 2002-06-27 | 2006-03-28 | Chugai Seiyaku Kabushiki Kaisya | Ferrocene compound and use thereof |
US8648075B2 (en) | 2007-08-01 | 2014-02-11 | Kumiai Chemical Industry Co., Ltd. | Substituted pyrido[2,3-b]pyrazines and an agrochemical composition thereof |
JP5291624B2 (en) * | 2007-08-01 | 2013-09-18 | クミアイ化学工業株式会社 | Oxopyrazine derivatives and herbicides |
US8389523B2 (en) | 2007-08-01 | 2013-03-05 | Kumiai Chemical Industry Co., Ltd. | Substituted quinoxaline and an agrochemical composition thereof |
EA017807B1 (en) * | 2007-08-01 | 2013-03-29 | Кумиай Кемикал Индастри Ко., Лтд. | Oxopyrazine derivative and herbicide |
WO2009016841A1 (en) * | 2007-08-01 | 2009-02-05 | Kumiai Chemical Industry Co., Ltd. | Oxopyrazine derivative and herbicide |
US8765920B2 (en) | 2009-12-23 | 2014-07-01 | The Scripps Research Institute | Tyrosine bioconjugation through aqueous Ene-like reactions |
EP2515914A4 (en) * | 2009-12-23 | 2013-09-11 | Scripps Research Inst | Tyrosine bioconjugation through aqueous ene-like reactions |
EP2515914A1 (en) * | 2009-12-23 | 2012-10-31 | The Scripps Research Institute | Tyrosine bioconjugation through aqueous ene-like reactions |
JP2017537331A (en) * | 2014-12-08 | 2017-12-14 | エフ.ホフマン−ラ ロシュ アーゲーF. Hoffmann−La Roche Aktiengesellschaft | Method for measuring vitamin D |
US11415576B2 (en) | 2014-12-08 | 2022-08-16 | Roche Diagnostics Operations, Inc. | Method for measurement of vitamin D |
JP2019214523A (en) * | 2018-06-12 | 2019-12-19 | 株式会社トクヤマ | Method for producing semicarbazide compound, and method for producing triazolidinedione compound |
US11034669B2 (en) | 2018-11-30 | 2021-06-15 | Nuvation Bio Inc. | Pyrrole and pyrazole compounds and methods of use thereof |
CN117417405A (en) * | 2023-12-15 | 2024-01-19 | 上海快序生物科技有限公司 | Peptide segment labeling method based on tyrosine derivatization and application of peptide segment labeling method in protein detection |
CN117417405B (en) * | 2023-12-15 | 2024-03-19 | 上海快序生物科技有限公司 | Peptide segment labeling method based on tyrosine derivatization and application of peptide segment labeling method in protein detection |
Also Published As
Publication number | Publication date |
---|---|
JP2638253B2 (en) | 1997-08-06 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR100191774B1 (en) | Pyrazolo(1,5-alpha)pyrimidine derivatives and anti-inflammatory agent containing them | |
FUJITA et al. | Fungal metabolites. Part 12. Potent immunosuppressant, 14-deoxomyriogin,(2s, 3r, 4r-(e) 2-amino-3, 4-dihydroxy-2-hydroxymethyleicos-6-enoic acid and structure-activity relationships of myriocin derivatives | |
JPH0737460B2 (en) | Pyranoindolizine derivative and method for producing the same | |
WO1992012991A1 (en) | Triterpene derivative | |
CN106660967A (en) | Process for the cycloaddition of a hetero(aryl) 1,3-dipole compound with a (hetero)cycloalkyne | |
Cavalieri et al. | Degradations in the purine series studied with isotopes of nitrogen and carbon | |
JPH045287A (en) | Reagent for determining vitamin ds and production thereof | |
FR2470774A1 (en) | NUCLEOSIDE DERIVATIVES, THEIR PREPARATION AND THEIR THERAPEUTIC USES | |
JP2000511556A (en) | Novel water-soluble C-ring analog of 20 (S) -camptothecin | |
Brown et al. | 2-Chloroadenine and 2-chloroadenosine | |
EP1979352A2 (en) | Pyridopyrimidone derivatives, preparation thereof, therapeutic use thereof | |
TW593328B (en) | Proactive antitumor compounds | |
US3992531A (en) | 2-Substituted adenosine-5'-carboxylates in the treatment of anginal pain | |
JP3466527B2 (en) | New aconitine compounds and analgesic / anti-inflammatory agents | |
CN102219803B (en) | Preparation method of ezetimibe intermediate | |
KR20000006339A (en) | A novel arabinosyladenine derivatives | |
EP0121806B1 (en) | Pyrazolo(1,5-a)pyridine derivatives and compositions containing them | |
Eaton et al. | Improved synthesis of DL-alanosine | |
JPH03101651A (en) | Production of amino group protected dopa or dopa derivative | |
CN113816924B (en) | Benzothiazinone derivative based on alkynyl connecting arm and preparation method and application thereof | |
Bryden et al. | 1, 3-DIMETHYL-5-IMINOTETRAZOLE, A NEW CYCLIC “MESO-IONIC” COMPOUND | |
Groziak et al. | Definitive Solution Structures for the 6-Formylated Versions of 1-(βD-Ribofuranosyl)-, 1-(2′-Deoxy-β-D-Ribofuranosyl)-, and 1-β-D-Arabinofuranosyluracil, and of Thymidine | |
JPH0381258A (en) | New dopa derivative | |
WO2023227006A1 (en) | Dideuterated camptothecin derivative and preparation method therefor | |
JPH02111747A (en) | Preparation of carbon 13-marked 5-aminolevulinic acid and derivative thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
S111 | Request for change of ownership or part of ownership |
Free format text: JAPANESE INTERMEDIATE CODE: R313113 |
|
S531 | Written request for registration of change of domicile |
Free format text: JAPANESE INTERMEDIATE CODE: R313531 |
|
R350 | Written notification of registration of transfer |
Free format text: JAPANESE INTERMEDIATE CODE: R350 |
|
R371 | Transfer withdrawn |
Free format text: JAPANESE INTERMEDIATE CODE: R371 |
|
S111 | Request for change of ownership or part of ownership |
Free format text: JAPANESE INTERMEDIATE CODE: R313113 |
|
S111 | Request for change of ownership or part of ownership |
Free format text: JAPANESE INTERMEDIATE CODE: R313113 |
|
R350 | Written notification of registration of transfer |
Free format text: JAPANESE INTERMEDIATE CODE: R350 |
|
EXPY | Cancellation because of completion of term |